Cinemark Usa 10-Q 11 May 16 2016 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2016	Apr. 30, 2016
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1
Trading Symbol	ck0000885975
Entity Registrant Name	CINEMARK USA INC /TX
Entity Central Index Key	885,975
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Class A common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,500
Class B common stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		182,648

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Mar. 31, 2016	Dec. 31, 2015
Current assets
Cash and cash equivalents		$ 583,809	$ 588,503
Inventories		15,300	15,954
Accounts receivable		67,979	74,287
Current income tax receivable		778	22,877
Prepaid expenses and other		17,958	13,494
Accounts receivable from parent		7,642	1,171
Total current assets		693,466	716,286
Theatre properties and equipment		2,758,309	2,687,391
Less: accumulated depreciation and amortization		1,232,450	1,182,322
Theatre properties and equipment, net		1,525,859	1,505,069
Other assets
Goodwill	[1]	1,258,686	1,247,548
Intangible assets-net		338,491	339,644
Investments in and advances to affiliates		87,031	94,973
Long-term deferred tax asset		2,133	2,114
Deferred charges and other assets-net		41,955	38,243
Total other assets		1,916,949	1,906,277
Total assets		4,136,274	4,127,632
Current liabilities
Current portion of long-term debt		8,397	8,405
Current portion of capital lease obligations		18,841	18,780
Current income tax payable		12,691	7,332
Current liability for uncertain tax positions		10,092	9,155
Accounts payable and accrued expenses		339,285	395,497
Total current liabilities		389,306	439,169
Long-term liabilities
Long-term debt, less current portion		1,793,907	1,772,930
Capital lease obligations, less current portion		206,368	208,952
Long-term deferred tax liability		137,177	139,905
Long-term liability for uncertain tax positions		7,905	7,853
Deferred lease expenses		42,918	43,333
Other long-term liabilities		48,033	60,105
Total long-term liabilities		$ 2,587,330	$ 2,575,212
Commitments and contingencies (see Note 16)
Cinemark USA, Inc.'s stockholder's equity:
Common stock		$ 49,543	$ 49,543
Treasury stock, 57,245 Class B shares at cost		(24,233)	(24,233)
Additional paid-in-capital		1,245,067	1,238,473
Retained earnings		137,893	110,049
Accumulated other comprehensive loss		(260,047)	(271,686)
Total Cinemark USA, Inc. stockholder's equity		1,148,223	1,102,146
Noncontrolling interests		11,415	11,105
Total equity		1,159,638	1,113,251
Total liabilities and equity		4,136,274	4,127,632
NCM
Other assets
Investment in NCM		188,653	183,755
Long-term liabilities
Deferred revenue-NCM		351,022	342,134
Class B common stock
Cinemark USA, Inc.'s stockholder's equity:
Common stock		$ 49,543	$ 49,543
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2016	Dec. 31, 2015
Treasury stock, shares at cost	57,245	57,245
Class A common stock
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	1,500	1,500
Common stock, shares outstanding	1,500	1,500
Class B common stock
Common stock, par value
Common stock, shares authorized	1,000,000	1,000,000
Common stock, shares issued	239,893	239,893
Common stock, shares outstanding	182,648	182,648

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Revenues
Admissions		$ 435,820	$ 400,662
Concession		237,815	214,427
Other		31,234	30,309
Total revenues		704,869	645,398
Cost of operations
Film rentals and advertising		232,914	207,610
Concession supplies		35,903	32,503
Salaries and wages		75,136	69,223
Facility lease expense		78,804	79,617
Utilities and other		81,377	83,406
General and administrative expenses		37,112	37,314
Depreciation and amortization		49,329	45,332
Impairment of long-lived assets		492	794
Gain on sale of assets and other		(1,779)	(1,450)
Total cost of operations		589,288	554,349
Operating income		115,581	91,049
Other income (expense)
Interest expense	[1]	(28,059)	(28,207)
Loss on early retirement of debt		(13,186)
Interest income		1,352	1,519
Foreign currency exchange gain (loss)		1,886	(8,206)
Distributions from NCM		8,543	8,499
Equity in income of affiliates		7,142	5,239
Total other income (expense)		(22,322)	(21,156)
Income before income taxes		93,259	69,893
Income taxes		33,744	26,611
Net income		59,515	43,282
Less: Net income attributable to noncontrolling interests		521	381
Net income attributable to Cinemark USA, Inc.		$ 58,994	$ 42,901
[1]	Includes amortization of debt issue costs.

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net income	$ 59,515	$ 43,282
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $118 and $453	201	757
Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes of $444		766
Other comprehensive income (loss) of equity method investments	(322)	384
Foreign currency translation adjustments, net of taxes of $979 and $0	13,780	(46,675)
Total other comprehensive income (loss), net of tax	13,659	(44,768)
Total comprehensive income (loss), net of tax	73,174	(1,486)
Comprehensive income attributable to noncontrolling interests	(530)	(387)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	$ 72,644	$ (1,873)

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 118	$ 453
Unrealized (loss) gain due to fair value adjustments on available-for-sale securities, taxes		444
Foreign currency translation adjustments, taxes	$ 979	$ 0

Condensed Consolidated Stateme7

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Operating activities
Net income		$ 59,515	$ 43,282
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation		48,839	44,731
Amortization of intangible and other assets and favorable/unfavorable leases		490	601
Amortization of long-term prepaid rents		471	713
Amortization of debt issue costs		1,286	1,312
Amortization of deferred revenues, deferred lease incentives and other		(5,243)	(3,255)
Impairment of long-lived assets		492	794
Share based awards compensation expense		4,870	3,273
Gain on sale of assets and other		(1,779)	(1,450)
Write-off of unamortized debt issue costs associated with early retirement of debt		2,369
Deferred lease expenses		(440)	(703)
Equity in income of affiliates		(7,142)	(5,239)
Deferred income tax expenses		(2,933)	(14,349)
Distributions from equity investees	[1]	8,086	7,264
Changes in assets and liabilities and other		(41,432)	(52,123)
Net cash provided by (used for) operating activities		67,449	24,851
Investing activities
Additions to theatre properties and equipment and other		(47,745)	(85,747)
Proceeds from sale of theatre properties and equipment and other		347	2,388
Proceeds from sale of marketable securities		13,451
Investment in joint ventures and other		(12)	(713)
Net cash provided by (used for) investing activities		(49,259)	(86,723)
Financing activities
Dividends paid to parent		(31,150)	(28,750)
Payroll taxes paid as a result of restricted stock withholdings		(5,610)	(4,748)
Proceeds from issuance of Senior Notes, net of discount		222,750
Retirement of Senior Subordinated Notes		(200,000)
Repayments of long-term debt		(1,758)	(1,758)
Payments of debt issue costs		(3,675)
Payments on capital leases		(4,572)	(3,913)
Other		1,503	2,244
Net cash provided by (used for) financing activities		(22,512)	(36,925)
Effect of exchange rate changes on cash and cash equivalents		(372)	(7,317)
Decrease in cash and cash equivalents		(4,694)	(106,114)
Cash and cash equivalents:
Beginning of period		588,503	638,841
End of period		583,809	532,727
Brazil
Investing activities
Acquisition of theatre			$ (2,651)
U.S.
Investing activities
Acquisition of theatre		$ (15,300)
[1]	Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow and for consistency with our peers, beginning with the three months ended March 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the three months ended March 31, 2015 has been recast to reflect comparable presentations.

The Company and Basis of Presen

The Company and Basis of Presentation	3 Months Ended
	Mar. 31, 2016
The Company and Basis of Presentation	1. The Company and Basis of Presentation Cinemark USA, Inc. and subsidiaries (the “Company”), a wholly-owned subsidiary of Cinemark Holdings, Inc., operates in the motion picture exhibition industry, with theatres in the United States (“U.S.”), Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia and Curacao. The accompanying condensed consolidated balance sheet as of December 31, 2015, which was derived from audited financial statements, and the unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete consolidated financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from these estimates. Majority-owned subsidiaries that the Company has control of are consolidated while those affiliates of which the Company owns between 20% and 50% and does not control are accounted for under the equity method. Those affiliates of which the Company owns less than 20% are generally accounted for under the cost method, unless the Company is deemed to have the ability to exercise significant influence over the affiliate, in which case the Company would account for its investment under the equity method. The results of these subsidiaries and affiliates are included in the condensed consolidated financial statements effective with their formation or from their dates of acquisition. Intercompany balances and transactions are eliminated in consolidation. These condensed consolidated financial statements should be read in conjunction with the audited annual consolidated financial statements and the notes thereto for the year ended December 31, 2015, included in the Annual Report on Form 10-K filed March 4, 2016 by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Operating results for the three months ended March 31, 2016 are not necessarily indicative of the results to be achieved for the full year. Accounting Reclassifications The Company has reclassified $8,049 in expenses from film rentals and advertising costs to utilities and other costs on the condensed consolidated statement of income for the three months ended March 31, 2015 to be consistent with the presentation for the three months ended March 31, 2016. During the three months ended March 31, 2016, the Company determined that reclassifying the expenses, which are related to the maintenance and monitoring of projection and sound equipment, results in a more clear presentation of film rental and advertising costs.

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	Mar. 31, 2016
New Accounting Pronouncements	2. New Accounting Pronouncements In February 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis In February 2016, the FASB issued Accounting Standards Update 2016-02, Leases (Topic 842) In March 2016, the FASB issued Accounting Standards Update 2016-04, Liabilities – Extinguishment of Liabilities (Subtopic 405-20) In March 2016, the FASB issued Accounting Standards Update 2016-07, Investments – Equity Method and Joint Ventures (Topic 323) In March 2016, the FASB issued Accounting Standards Update 2016-08, Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenues Gross versus Net) Revenue from Contracts with Customers (Topic 606) In March 2016, the FASB issued Accounting Standards Update 2016-09, Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting

Long Term Debt Activity

Long Term Debt Activity	3 Months Ended
	Mar. 31, 2016
Long Term Debt Activity	3. Long Term Debt Activity Issuance of Additional 4.875% Senior Notes On March 21, 2016, Cinemark USA, Inc. issued an additional $225,000 aggregate principal amount of 4.875% senior notes due 2023 (the “4.875% Senior Notes”), at 99.0% of the principal amount plus accrued and unpaid interest from December 1, 2015. Proceeds, after payment of fees, were used to finance the redemption of Cinemark, USA, Inc.’s $200,000 7.375% senior subordinated notes due 2021 (the “7.375% Senior Subordinated Notes”), as discussed below. These additional notes have identical terms, other than the issue date, the issue price and the first interest payment date, and constitute part of the same series as Cinemark USA, Inc.’s existing 4.875% Senior Notes. The aggregate principal amount of $755,000 of 4.875% Senior Notes mature on June 1, 2023. The Company incurred debt issue costs of approximately $3,656 in connection with the issuance of the additional notes, which, along with the discount of $2,250, are reflected as a reduction of long term debt as of March 31, 2016. On April 5, 2016, Cinemark USA, Inc. and its guarantor subsidiaries filed a registration statement with the Securities and Exchange Commission (the “Commission”), pursuant to which Cinemark USA, Inc. offered to exchange the additional 4.875% Senior Notes for substantially identical notes registered under the Securities Act of 1933, as amended, that do not contain terms restricting the transfer thereof or providing for registration rights. The registration statement was declared effective April 18, 2016, and the notes are expected to be exchanged by May 16, 2016. Redemption of 7.375% Senior Subordinated Notes On March 21, 2016, Cinemark USA, Inc. redeemed its $200,000 7.375% Senior Subordinated Notes at a make-whole premium of approximately 104% plus accrued and unpaid interest, utilizing the proceeds from the issuance of the additional $225,000 Cinemark USA, Inc. 4.875% Senior Notes discussed above. As a result of the redemption, the Company wrote-off approximately $2,369 in unamortized debt issue costs, paid the make-whole premium of $9,670 and paid other fees of $1,147, all of which are reflected in loss on early retirement of debt during the three months ended March 31, 2016. Fair Value of Long-Term Debt The Company estimates the fair value of its long-term debt using the market approach, which utilizes quoted market prices that fall under Level 2 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, Fair Value Measurement

Equity

Equity	3 Months Ended
	Mar. 31, 2016
Equity	4. Equity Below is a summary of changes in stockholders’ equity attributable to Cinemark USA, Inc., noncontrolling interests and total equity for the three months ended March 31, 2016 and 2015: Cinemark USA, Inc. Stockholder’s Noncontrolling Total Equity Interests Equity Balance at January 1, 2016 $ 1,102,146 $ 11,105 $ 1,113,251 Share based awards compensation expense 4,870 — 4,870 Tax benefit related to share based awards vesting 1,724 — 1,724 Cash dividends paid to parent (31,150 ) — (31,150 ) Dividends paid to noncontrolling interests — (220 ) (220 ) Net income 58,994 521 59,515 Fair value adjustments on interest rate swap agreements designated as hedges, net of settlements, net of taxes of $118 201 — 201 Gain realized on available-for-sale securities, net of taxes of $1,180 (2,011 ) — (2,011 ) Other comprehensive loss in equity method investees (322 ) — (322 ) Foreign currency translation adjustments 13,771 9 13,780 Balance at March 31, 2016 $ 1,148,223 $ 11,415 $ 1,159,638 Cinemark USA, Inc. Stockholder’s Noncontrolling Total Equity Interests Equity Balance at January 1, 2015 $ 1,126,394 $ 10,329 $ 1,136,723 Share based awards compensation expense 3,273 — 3,273 Tax benefit related to share based awards vesting 2,244 — 2,244 Cash and noncash dividends to parent (46,686 ) — (46,686 ) Net income 42,901 381 43,282 Fair value adjustments on interest rate swap agreements designated as hedges, net of settlements, net of taxes of $453 757 — 757 Fair value adjustments on available-for-sale securities, net of taxes of $444 766 — 766 Other comprehensive income in equity method investees 384 — 384 Foreign currency translation adjustments (46,681 ) 6 (46,675 ) Balance at March 31, 2015 $ 1,083,352 $ 10,716 $ 1,094,068

Investment in National CineMedi

Investment in National CineMedia	3 Months Ended
	Mar. 31, 2016
NCM
Investment in National CineMedia	5. Investment in National CineMedia The Company has an investment in National CineMedia, LLC (“NCM”). NCM operates a digital in-theatre network in the U.S. for providing cinema advertising. Upon joining NCM, the Company entered into an Exhibitor Services Agreement with NCM (“ESA”), pursuant to which NCM provides advertising, promotion and event services to our theatres. As described further in Note 4 to the Company’s financial statements as included in its 2015 Annual Report on Form 10-K, on February 13, 2007, National CineMedia, Inc. (“NCM, Inc.”), an entity that serves as the sole manager of NCM, completed an initial public offering (“IPO”) of its common stock. In connection with the NCM Inc. initial public offering, the Company amended its operating agreement and the ESA. Following the NCM, Inc. IPO, the Company does not recognize undistributed equity in the earnings on its original NCM membership units (referred to herein as the Company’s Tranche 1 Investment) until NCM’s future net earnings, less distributions received, surpass the amount of the excess distribution. The Company recognizes equity in earnings on its Tranche 1 Investment only to the extent it receives cash distributions from NCM. The Company recognizes cash distributions it receives from NCM on its Tranche 1 Investment as a component of earnings as Distributions from NCM. The Company believes that the accounting model provided by ASC 323-10-35-22 for recognition of equity investee losses in excess of an investor’s basis is analogous to the accounting for equity income subsequent to recognizing an excess distribution. Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements: Distributions Investment Deferred from Equity in Other Cash in NCM Revenue NCM Income Revenue Received Balance as of January 1, 2016 $ 183,755 $ (342,134 ) Receipt of common units due to annual common unit adjustment 11,111 (11,111 ) $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (2,806 ) 2,806 Receipt of excess cash distributions (5,321 ) — (5,602 ) — — 10,923 Receipt under tax receivable agreement (2,765 ) — (2,941 ) — — 5,706 Equity in earnings 1,873 — — (1,873 ) — — Amortization of deferred revenue — 2,223 — — (2,223 ) — Balance as of and for the three month period ended March 31, 2016 $ 188,653 $ (351,022 ) $ (8,543 ) $ (1,873 ) $ (5,029 ) $ 19,435 (1) Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $2,586. During the three months ended March 31, 2016 and 2015, the Company recorded equity in earnings of approximately $1,873 and $795, respectively. The Company made payments to NCM of approximately $22 and $20 during the three months ended March 31, 2016 and 2015, respectively, related to installation of certain equipment used for digital advertising, which is included in theatre properties and equipment on the condensed consolidated balance sheets. Pursuant to a Common Unit Adjustment Agreement dated as of February 13, 2007 between NCM, Inc. and the Company, AMC Entertainment, Inc. (“AMC”) and Regal Entertainment Group (“Regal”), annual adjustments to the common membership units are made primarily based on increases or decreases in the number of theatre screens operated and theatre attendance generated by each Founding Member. As further discussed in Note 6 to the Company’s financial statements as included in its 2015 Annual Report on Form 10-K, the common units received are recorded at fair value as an increase in the Company’s investment in NCM with an offset to deferred revenue. The deferred revenue is amortized over the remaining term of the ESA. During March 2016, NCM performed its annual common unit adjustment calculation under the Common Unit Adjustment Agreement. As a result of the calculation, the Company received an additional 753,598 common units of NCM, each of which is convertible into one share of NCM, Inc. common stock. The Company recorded the additional common units received at fair value with a corresponding adjustment to deferred revenue of approximately $11,111. The deferred revenue will be recognized over the remaining term of the ESA, which is approximately 20 years. As of March 31, 2016, the Company owned a total of 26,384,644 common units of NCM, representing an ownership interest of approximately 19%. The estimated fair value of the Company’s investment in NCM was approximately $401,310 as of March 31, 2016, using NCMI’s stock price as of March 31, 2016 of $15.21 per share. Below is summary financial information for NCM for the periods indicated: Quarter Ended Quarter Ended March 31, 2016 April 2, 2015 Gross revenues $ 76,242 $ 76,867 Operating income (loss) $ 5,751 $ (24,111 ) Net loss $ (7,510 ) $ (38,729 )

Other Investments

Other Investments	3 Months Ended
	Mar. 31, 2016
Other Investments	6. Other Investments The Company had the following other investments at March 31, 2016: Digital Cinema Implementation Partners LLC (“DCIP”), equity method investment $ 75,690 AC JV, LLC, equity method investment 7,636 Digital Cinema Distribution Coalition (“DCDC”), equity method investment 3,043 Other 662 Total $ 87,031 Below is a summary of activity for each of the investments for the three months ended March 31, 2016: DCIP RealD AC JV, DCDC Other Total Balance at January 1, 2016 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ 663 $ 94,973 Cash contributions 12 — — — — 12 Equity in income 4,421 — 367 481 — 5,269 Equity in comprehensive loss (322 ) — — — — (322 ) Sale of investment (1) — (12,900 ) — — — (12,900 ) Other — — — — (1 ) (1 ) Balance at March 31, 2016 $ 75,690 $ — $ 7,636 $ 3,043 $ 662 $ 87,031 (1) See further discussion of the sale of the investment held by the Company under RealD, Inc. below. Digital Cinema Implementation Partners LLC On February 12, 2007, the Company, AMC and Regal entered into a joint venture known as DCIP to facilitate the implementation of digital cinema in the Company’s theatres and to establish agreements with major motion picture studios for the financing of digital cinema. On March 10, 2010, the Company signed a master equipment lease agreement and other related agreements (collectively the “Agreements”) with Kasima LLC (“Kasima”), which is an indirect subsidiary of DCIP and a related party to the Company. Upon signing the Agreements, the Company contributed the majority of its U.S. digital projection systems to DCIP, which DCIP then contributed to Kasima. The Company has a variable interest in Kasima through the terms of its master equipment lease agreement; however, the Company has determined that it is not the primary beneficiary of Kasima, as the Company does not have the ability to direct the activities of Kasima that most significantly impact Kasima’s economic performance. As of March 31, 2016, the Company had a 33% voting interest in DCIP and a 24.3% economic interest in DCIP. The Company accounts for its investment in DCIP and its subsidiaries under the equity method of accounting. Below is summary financial information for DCIP for the three months ended March 31, 2016 and 2015: Three Months Ended March 31, 2016 March 31, 2015 Revenues $ 40,644 $ 40,741 Operating income $ 23,400 $ 23,764 Net income $ 18,502 $ 17,444 As of March 31, 2016, the Company had 3,781 digital projection systems being leased under the master equipment lease agreement with Kasima. The Company had the following transactions, recorded in utilities and other on the condensed consolidated income statement, with DCIP during the three months ended March 31, 2016 and 2015: Three Months Ended 2016 2015 Equipment lease payments $ 1,125 $ 1,010 Warranty reimbursements from DCIP $ (1,324 ) $ (957 ) RealD, Inc. The Company licenses 3-D systems from RealD. Under its license agreement with RealD, the Company earned options to purchase shares of RealD common stock as it installed a certain number of 3-D systems as outlined in the license agreement. During 2010 and 2011, the Company vested in a total of 1,222,780 RealD options. Upon vesting in these options, the Company recorded an investment in RealD and a deferred lease incentive liability using the estimated fair value of the RealD options at the time of vesting. During March 2011, the Company exercised all of its options to purchase shares of common stock in RealD for $0.00667 per share. On March 22, 2016, an affiliate of Rizvi Traverse Management, LLC acquired RealD for $11.00 per share. As a result of the transaction, the Company sold its shares for approximately $13,451 and recognized a gain of $3,742, which included the recognition of a cumulative unrealized holding gain of $3,191 previously recorded in accumulated other comprehensive loss. The gain is reflected as gain on sale of assets and other on the condensed consolidated statement of income for the three months ended March 31, 2016. The Company plans to use the proceeds to make a pre-payment on its term loan in accordance with the terms of its senior secured credit facility. The Company paid licensing fees of $1,895 and $1,156 to RealD during the three months ended March 31, 2016 and 2015, respectively, which are included in utilities and other costs on the condensed consolidated statements of income. AC JV, LLC During December 2013, the Company, Regal, AMC (the “AC Founding Members”) and NCM entered into a series of agreements that resulted in the formation of AC JV, LLC (“AC”), a new joint venture that now owns “Fathom Events” (consisting of Fathom Events and Fathom Consumer Events) formerly operated by NCM. The Fathom Events business focuses on the marketing and distribution of live and pre-recorded entertainment programming to various theatre operators to provide additional programs to augment their feature film schedule. The Fathom Consumer Events business includes live and pre-recorded concerts featuring contemporary music, opera and symphony, DVD product releases and marketing events, theatrical premieres, Broadway plays, live sporting events and other special events. The Company paid event fees of $2,930 and $3,401 for the three months ended March 31, 2016 and 2015, respectively, which are included in film rentals and advertising costs on the condensed consolidated statements of income. AC was formed by the AC Founding Members and NCM. NCM, under a contribution agreement, contributed the assets associated with its Fathom Events division to AC in exchange for 97% ownership of the Class A Units of AC. Under a separate contribution agreement, the Founding Members each contributed cash of approximately $268 to AC in exchange for 1% of the Class A Units of AC. Subsequently, NCM and the Founding Members entered into a Membership Interest Purchase Agreement, under which NCM sold each of the Founding Members 31% of its Class A Units in AC, the aggregate value of which was determined to be $25,000, in exchange for a six-year Promissory Note. Each of the Founding Members’ Promissory Notes were originally for $8,333, bear interest at 5% per annum and require annual principal and interest payments, with the first of such payments made during December 2014. The remaining outstanding balance of the note payable from the Company to AC as of March 31, 2016 was $5,555. Digital Cinema Distribution Coalition Digital Cinema Distribution Coalition (“DCDC”) is a joint venture among the Company, Universal, Warner Bros., AMC and Regal. DCDC operates a satellite distribution network that distributes all digital content to U.S. theatres via satellite. The Company has an approximate 14.6% ownership in DCDC. The Company paid approximately $307 and $208 during the three months ended March 31, 2016 and 2015, respectively, related to content delivery services provided by DCDC. These fees are included in film rentals and advertising costs on the condensed consolidated statements of income.

Share Based Awards

Share Based Awards	3 Months Ended
	Mar. 31, 2016
Share Based Awards	7. Share Based Awards Restricted Stock Below is a summary of restricted stock activity for the three months ended March 31, 2016: Shares of Weighted Restricted Grant Date Stock Fair Value Outstanding at January 1, 2016 757,775 $ 30.73 Granted 269,214 $ 29.83 Vested (375,585 ) $ 24.70 Forfeited (30,170 ) $ 33.06 Outstanding at March 31, 2016 621,234 $ 33.86 Unvested restricted stock at March 31, 2016 621,234 $ 33.86 Three Months Ended March 31, 2016 2015 Compensation expense recognized during the period (1) $ 2,653 $ 2,365 Fair value of restricted shares that vested during the period $ 12,742 $ 13,161 Income tax deduction upon vesting of restricted stock awards $ 4,748 $ 3,311 (1) Cinemark Holdings, Inc. recorded an additional $248 and $225 of compensation expense related to these restricted stock awards during the quarters ended March 31, 2016 and 2015, respectively. As of March 31, 2016, the estimated remaining unrecognized compensation expense related to restricted stock awards was $16,277, of which $16,070 will be recognized by the Company and an additional $207 of which will be recognized by Cinemark Holdings, Inc. The weighted average period over which this remaining compensation expense will be recognized is approximately three years. Restricted Stock Units year period is at least 6.0%, which is the threshold, one-third of the maximum restricted stock units vest. If the IRR for the two-year period is at least 8.0%, which is the target, two-thirds of the maximum restricted stock units vest. If the IRR for the two-year period is at least 10.0%, which is the maximum, 100% of the maximum restricted stock units vest. Grantees are eligible to receive a ratable portion of the common stock issuable if the IRR is within the targets previously noted. Further, as an example, if the Company achieves an IRR equal to 9.0%, the number of restricted stock units that shall vest will be greater than the target but less than the maximum number that would have vested had the Company achieved the highest IRR. In accordance with their respective employment agreements, the awards granted to the Company’s former Chief Executive Officer and former President and Chief Operating Officer vest upon the certification of the IRR for the 2016 award by the Compensation Committee. All other restricted stock units granted during 2016 will vest subject to an additional two-year service requirement and will be paid in the form of Cinemark Holdings, Inc.’s common stock if the participant continues to provide services through February 2020, which is the fourth anniversary of the grant date. Restricted stock unit award participants are eligible to receive dividend equivalent payments from the grant date if, and at the time that, the restricted stock unit awards vest. Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the three months ended March 31, 2016 at each of the three target levels of financial performance (excluding forfeiture assumptions): Number of Shares Value at Vesting Grant at IRR of at least 6.0% 84,554 $ 2,522 at IRR of at least 8.0% 169,107 $ 5,044 at IRR of at least 10.0% 253,661 $ 7,568 Due to the fact that the IRR for the two-year performance period could not be determined at the time of the 2016 grant, the Company estimated that the most likely outcome is the achievement of the target IRR level. The fair value of the restricted stock unit awards was determined based on the closing price of Cinemark Holdings, Inc.’s common stock on the date of grant, which was $29.83 per share. The Company assumed forfeiture rates ranging from 0% to 10% for the restricted stock unit awards. If during the service period, additional information becomes available to lead the Company to believe a different IRR level will be achieved for the two-year performance period, the Company will reassess the number of units that will vest for the grant and adjust its compensation expense accordingly on a prospective basis over the remaining service period. Three Months Ended March 31, 2016 2015 Number of restricted stock unit awards that vested during the period 143,872 123,769 Fair value of restricted stock unit awards that vested during the period $ 4,747 $ 5,501 Accumulated dividends paid upon vesting of restricted stock unit awards (1) $ 404 $ 46 Income tax benefit recognized upon vesting of restricted stock unit awards $ 1,993 $ 2,303 Compensation expense recognized during the period $ 2,217 $ 908 (1) Additional dividends of approximately $396 were paid during April 2015 related to the restricted stock unit awards that vested during the three months ended March 31, 2015. As of March 31, 2016, the estimated remaining unrecognized compensation expense related to the outstanding restricted stock unit awards was $8,492. The weighted average period over which this remaining compensation expense will be recognized is approximately two years. As of March 31, 2016, the Company had restricted stock units outstanding that represented a total of 643,400 hypothetical shares of common stock, net of actual cumulative forfeitures of 17,917 units, assuming the maximum IRR level is achieved for all grants outstanding. Effective March 4, 2016, the Company’s former President and Chief Operating Officer resigned with good reason as defined within his employment agreement. As a result, certain of his restricted stock and restricted stock unit awards vested upon his resignation. The accelerated vesting of these awards were considered a modification of such awards, therefore the Company revalued the vested awards at their fair value upon modification. The revaluation of these awards resulted in incremental share based award compensation expense of approximately $994 for the three months ended March 31, 2016.

Interest Rate Swap Agreements

Interest Rate Swap Agreements	3 Months Ended
	Mar. 31, 2016
Interest Rate Swap Agreements	8. Interest Rate Swap Agreements The Company is currently a party to one interest rate swap agreement that is used to hedge interest rate risk associated with the variable interest rates on the Company’s term loan debt and qualify for cash flow hedge accounting. The fair value of the interest rate swap is recorded on the Company’s condensed consolidated balance sheet as an asset or liability with the effective portion of the interest rate swap’s gains or losses reported as a component of accumulated other comprehensive loss and the ineffective portion reported in earnings. The changes in fair values are reclassified from accumulated other comprehensive loss into earnings in the same period that the hedged item affects earnings. The valuation technique used to determine fair value is the income approach and under this approach, the Company uses projected future interest rates as provided by its swap counterparty and the fixed rate that the Company is obligated to pay under the agreement. Therefore, the Company’s measurements use significant unobservable inputs, which fall in Level 3 of the U.S. GAAP hierarchy as defined by FASB ASC Topic 820-10-35. There were no changes in valuation techniques during the period and no transfers in or out of Level 3. See Note 11 for a summary of unrealized gains or losses recorded in accumulated other comprehensive loss and earnings. Below is a summary of the Company’s current interest rate swap agreement designated as a cash flow hedge as of March 31, 2016: Nominal Amount Effective Date Pay Rate Receive Rate Expiration Date Estimated Total Fair Value at March 31, 2016 (1) $ 100,000 November 2011 1.7150 % 1-Month LIBOR April 2016 $ 53 (1) Included in accounts payable and accrued expenses on the condensed consolidated balance sheet as of March 31, 2016. The changes in accumulated other comprehensive loss, net of taxes, related to the Company’s interest rate swap agreements for the three months ended March 31, 2016 and 2015 were as follows: Interest Rate Swaps 2016 2015 Beginning balances – January 1 $ (234 ) $ (2,870 ) Other comprehensive loss before reclassifications, net of taxes (133 ) (689 ) Amounts reclassified from accumulated other comprehensive loss to interest expense, net of taxes 334 1,446 Net other comprehensive income 201 757 Ending balances – March 31 $ (33 ) $ (2,113 )

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2016
Goodwill and Other Intangible Assets	9. Goodwill and Other Intangible Assets The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at January 1, 2016 (1) $ 1,156,556 $ 90,992 $ 1,247,548 Acquisition of U.S. theatres 8,350 — 8,350 Foreign currency translation adjustments — 2,788 2,788 Balance at March 31, 2016 (1) $ 1,164,906 $ 93,780 $ 1,258,686 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment. The Company evaluates goodwill for impairment annually during the fourth quarter or whenever events or changes in circumstances indicate the carrying value of the goodwill may not be fully recoverable. The Company evaluates goodwill for impairment at the reporting unit level and has allocated goodwill to the reporting unit based on an estimate of its relative fair value. Management considers the reporting unit to be each of its nineteen regions in the U.S. and seven countries internationally (Honduras, El Salvador, Nicaragua, Costa Rica, Panama and Guatemala are considered one reporting unit). For the year ended December 31, 2015, the Company performed a qualitative goodwill impairment assessment on all reporting units except one, in accordance with ASU 2011-08 Testing Goodwill for Impairment No events or changes in circumstances occurred during the three months ended March 31, 2016 that indicated the carrying value of goodwill might exceed its estimated fair value. Intangible assets consisted of the following: Balance at Amortization Other (1) Balance at Intangible assets with finite lives: Gross carrying amount $ 99,968 $ — $ (642 ) $ 99,326 Accumulated amortization (59,706 ) (1,338 ) 661 (60,383 ) Total net intangible assets with finite lives $ 40,262 (1,338 ) 19 $ 38,943 Intangible assets with indefinite lives: Tradename 299,382 — 166 299,548 Total intangible assets — net $ 339,644 $ (1,338 ) $ 185 $ 338,491 (1) Includes non-compete agreement related to the acquisition of U.S. theatres, write-off of a fully amortized vendor contract, and foreign currency translation adjustments. Estimated aggregate future amortization expense for intangible assets is as follows: For the nine months ended December 31, 2016 $ 3,975 For the twelve months ended December 31, 2017 4,957 For the twelve months ended December 31, 2018 4,882 For the twelve months ended December 31, 2019 3,977 For the twelve months ended December 31, 2020 4,252 Thereafter 16,900 Total $ 38,943

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets	3 Months Ended
	Mar. 31, 2016
Impairment of Long-Lived Assets	10. Impairment of Long-Lived Assets The Company reviews long-lived assets for impairment indicators on a quarterly basis or whenever events or changes in circumstances indicate the carrying amount of the assets may not be fully recoverable. The Company considers actual theatre level cash flows, budgeted theatre level cash flows, theatre property and equipment carrying values, amortizing intangible asset carrying values, the age of a recently built theatre, competitive theatres in the marketplace, the impact of recent ticket price changes, available lease renewal options and other factors considered relevant in its assessment of impairment of individual theatre assets. Long-lived assets are evaluated for impairment on an individual theatre basis, which the Company believes is the lowest applicable level for which there are identifiable cash flows. The impairment evaluation is based on the estimated undiscounted cash flows from continuing use through the remainder of the theatre’s useful life. The remainder of the theatre’s useful life correlates with the available remaining lease period, which includes the probability of renewal periods, for leased properties and the lesser of twenty years or the building’s remaining useful life for fee-owned properties. If the estimated undiscounted cash flows are not sufficient to recover a long-lived asset’s carrying value, the Company then compares the carrying value of the asset group (theatre) with its estimated fair value. When estimated fair value is determined to be lower than the carrying value of the asset group (theatre), the asset group (theatre) is written down to its estimated fair value. Significant judgment is involved in estimating cash flows and fair value. Management’s estimates, which fall under Level 3 of the U.S. GAAP fair value hierarchy as defined by FASB ASC Topic 820-10-35, are based on historical and projected operating performance, recent market transactions and current industry trading multiples. Fair value is determined based on a multiple of cash flows, which was six and a half times for the evaluations performed during the three months ended March 31, 2016 and 2015. As of March 31, 2016, the estimated aggregate fair value of the long-lived assets impaired during the three months ended March 31, 2016 was approximately $1,770. The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Three Months Ended March 31, 2016 2015 United States theatre properties $ 136 $ 794 International theatre properties 356 — Impairment of long-lived assets $ 492 $ 794

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2016
Fair Value Measurements	11. Fair Value Measurements The Company determines fair value measurements in accordance with FASB ASC Topic 820, which establishes a fair value hierarchy under which an asset or liability is categorized based on the lowest level of input significant to its fair value measurement. The levels of input defined by FASB ASC Topic 820 are as follows: Level 1 – quoted market prices in active markets for identical assets or liabilities that are accessible at the measurement date; Level 2 – other than quoted market prices included in Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3 – unobservable and should be used to measure fair value to the extent that observable inputs are not available. Below is a summary of assets and liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of March 31, 2016: Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities – current (see Note 8) $ (53 ) $ — $ — $ (53 ) Below is a summary of assets and liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2015: Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities – current (see Note 8) $ (373 ) $ — $ — $ (373 ) Investment in RealD (see Note 6) $ 12,900 $ 12,900 $ — $ — Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities 2016 2015 Beginning balances —January 1 $ 373 $ 4,572 Total loss included in accumulated other comprehensive loss 14 236 Settlements (334 ) (1,446 ) Ending balances – March 31 $ 53 $ 3,362 The Company also uses the market approach for fair value measurements on a nonrecurring basis in the impairment evaluations of its long-lived assets (see Note 9 and Note 10). Additionally, the Company uses the market approach to estimate the fair value of its long-term debt (see Note 3). There were no changes in valuation techniques and there were no transfers in or out of Level 1, Level 2 or Level 3 during the three months ended March 31, 2016.

Foreign Currency Translation

Foreign Currency Translation	3 Months Ended
	Mar. 31, 2016
Foreign Currency Translation	12. Foreign Currency Translation The accumulated other comprehensive loss account in stockholder’s equity of $260,047 and $271,686 at March 31, 2016 and December 31, 2015, respectively, includes cumulative foreign currency adjustments of $259,633 and $273,404, respectively, from translating the financial statements of the Company’s international subsidiaries, and also includes the change in fair values of the Company’s interest rate swap agreements that are designated as hedges and the change in fair value of the Company’s available-for-sale securities. All foreign countries where the Company has operations are non-highly inflationary, and the local currency is the same as the functional currency in all of the locations. Thus, any fluctuation in the currency results in a cumulative foreign currency translation adjustment recorded to accumulated other comprehensive loss. Below is a summary of the impact of translating the March 31, 2016 financial statements of the Company’s international subsidiaries: Other Comprehensive Income (Loss) for The Exchange Rate as of Three Months Ended Country March 31, 2016 December 31, 2015 March 31, 2016 Brazil 3.60 3.96 $ 18,298 Argentina 14.62 12.95 (7,151 ) Colombia 3,022.35 3,149.47 1,109 Chile 691.65 709.16 1,106 Peru 3.42 3.46 444 All other (35 ) $ 13,771

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	3 Months Ended
	Mar. 31, 2016
Supplemental Cash Flow Information	13. Supplemental Cash Flow Information The following is provided as supplemental information to the condensed consolidated statements of cash flows: Three Months Ended March 31, 2016 2015 Cash paid for interest $ 15,503 $ 11,358 Cash paid for income taxes, net of refunds received $ 6,259 $ 6,552 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ 3,055 $ 2,384 Theatre properties acquired under capital lease $ — $ 3,100 Investment in NCM – receipt of common units (see Note 5) $ 11,111 $ 15,421 Noncash dividends to Cinemark Holdings, Inc. $ — $ (17,936 ) (1) Additions to theatre properties and equipment included in accounts payable as of March 31, 2016 and December 31, 2015 were $14,209 and $11,154, respectively.

Segments

Segments	3 Months Ended
	Mar. 31, 2016
Segments	14. Segments The Company manages its international market and its U.S. market as separate reportable operating segments, with the international segment consisting of operations in Brazil, Argentina, Chile, Colombia, Peru, Ecuador, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia and Curacao. Each segment’s revenue is derived from admissions and concession sales and other ancillary revenues, primarily screen advertising. The Company uses Adjusted EBITDA, as shown in the reconciliation below, as measure of segment profit and loss to evaluate performance and allocate its resources. The Company does not report asset information by segment because that information is not used to evaluate the performance of or allocate resources between segments. Below is a breakdown of selected financial information by reportable operating segment: Three Months Ended March 31, 2016 2015 Revenues U.S. $ 543,915 $ 474,295 International 164,175 174,333 Eliminations (3,221 ) (3,230 ) Total revenues $ 704,869 $ 645,398 Adjusted EBITDA (1) U.S. $ 144,139 $ 114,757 International 41,014 40,014 Total Adjusted EBITDA $ 185,153 $ 154,771 Capital expenditures U.S. $ 41,198 $ 74,267 International 6,547 11,480 Total capital expenditures $ 47,745 $ 85,747 (1) Distributions from equity method investees are reported entirely within the U.S. operating segment. The following table sets forth a reconciliation of net income to Adjusted EBITDA: Three Months Ended March 31, 2016 2015 Net income $ 59,515 $ 43,282 Add (deduct): Income taxes 33,744 26,611 Interest expense (1) 28,059 28,207 Other (income) expense (2) (10,380 ) 1,448 Loss on early retirement of debt 13,186 — Other cash distributions from equity investees (3) 8,086 7,264 Depreciation and amortization 49,329 45,332 Impairment of long-lived assets 492 794 Gain on sale of assets and other (1,779 ) (1,450 ) Deferred lease expenses (440 ) (703 ) Amortization of long-term prepaid rents 471 713 Share based awards compensation expense 4,870 3,273 Adjusted EBITDA $ 185,153 $ 154,771 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange (gain) loss and equity in income of affiliates and excludes distributions from NCM. (3) Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow and for consistency with our peers, beginning with the three months ended March 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the three months ended March 31, 2015 has been recast to reflect comparable presentations. Financial Information About Geographic Areas Below is a breakdown of selected financial information by geographic area: Three Months Ended March 31, Revenues 2016 2015 U.S. $ 543,915 $ 474,295 Brazil 71,509 78,293 Other international countries 92,666 96,040 Eliminations (3,221 ) (3,230 ) Total $ 704,869 $ 645,398 Theatre Properties and Equipment-net March 31, 2016 December 31, 2015 U.S. $ 1,187,753 $ 1,175,535 Brazil 177,728 163,505 Other international countries 160,378 166,029 Total $ 1,525,859 $ 1,505,069

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2016
Related Party Transactions	15. Related Party Transactions The Company manages theatres for Laredo Theatres, Ltd. (“Laredo”). The Company is the sole general partner and owns 75% of the limited partnership interests of Laredo. Lone Star Theatres, Inc. owns the remaining 25% of the limited partnership interests in Laredo and is 100% owned by Mr. David Roberts, Lee Roy Mitchell’s son-in-law. Lee Roy Mitchell is Cinemark Holdings, Inc.’s Chairman of the Board and directly and indirectly owns approximately 9% of Cinemark Holdings, Inc.’s common stock. Under the agreement, management fees are paid by Laredo to the Company at a rate of 5% of annual theatre revenues up to $50,000 and 3% of annual theatre revenues in excess of $50,000. The Company recorded $128 and $135 of management fee revenues during the three months ended March 31, 2016 and 2015, respectively. All such amounts are included in the Company’s condensed consolidated financial statements with the intercompany amounts eliminated in consolidation. The Company has an Aircraft Time Sharing Agreement with Copper Beech Capital, LLC to use, on occasion, a private aircraft owned by Copper Beech Capital, LLC. Copper Beech Capital, LLC is owned by Mr. Mitchell and his wife, Tandy Mitchell. The private aircraft is used by Mr. Mitchell and other executives who accompany Mr. Mitchell to business meetings for the Company. The Company reimburses Copper Beech Capital, LLC for the actual costs of fuel usage and the expenses of the pilots, landing fees, storage fees and similar expenses incurred during the trip. For the three months ended March 31, 2016 and 2015, the aggregate amounts paid to Copper Beech Capital, LLC for the use of the aircraft was $24 and $37, respectively. The Company currently leases 15 theatres and one parking facility from Syufy Enterprises, LP (“Syufy”) or affiliates of Syufy. Raymond Syufy is one of Cinemark Holdings, Inc.’s directors and is an officer of the general partner of Syufy. Of these 16 leases, 15 have fixed minimum annual rent. The one lease without minimum annual rent has rent based upon a specified percentage of gross sales as defined in the lease. For the three months ended March 31, 2016 and 2015, the Company paid total rent of $6,857 and $5,566, respectively, to Syufy. The Company has paid certain fees on behalf of its parent, Cinemark Holding, Inc., and Cinemark Holdings, Inc. has paid income taxes and other items on behalf of the Company. The net receivable from Cinemark Holdings, Inc. as of March 31, 2016 and December 31, 2015 was $7,642 and $1,171, respectively. The Company paid Cinemark Holdings, Inc. dividends of $31,150 and $46,686 during the three months ended March 31, 2016 and 2015, respectively. Of the dividends paid during the three months ended March 31, 2015, $17,936 was noncash.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2016
Commitments and Contingencies	16. Commitments and Contingencies Effective March 4, 2016, the Company’s former President and Chief Operating Officer Robert Copple resigned with good reason as defined within his employment agreement. The Company paid Mr. Copple the payments and benefits pursuant to the terms set forth in his employment agreement. The Company’s post-termination obligations, such as providing continued participation in the Company’s welfare benefit plans and insurance programs, remain in effect for a limited period of time under the employment agreement. Joseph Amey, et al. v. Cinemark USA, Inc., Case No. 3:13cv05669, In the United States District Court for the Northern District of California, San Francisco Division. The Company received a Civil Investigative Demand (“CID”) from the Antitrust Division of the United States Department of Justice. The CID relates to an investigation under Sections 1 and 2 of the Sherman Act. The Company also received CIDs from the Antitrust Section of the Office of the Attorney General of the State of Ohio and later from other states regarding similar inquiries under state antitrust laws. The CIDs request the Company to answer interrogatories, and produce documents, or both, related to the investigation of matters including film clearances, potential coordination and/or communication with other major theatre circuits and related joint ventures. The Company intends to fully cooperate with all federal and state government agencies. Although the Company does not believe that it has violated any federal or state antitrust or competition laws, it cannot predict the ultimate scope, duration or outcome of these investigations. From time to time, the Company is involved in various other legal proceedings arising from the ordinary course of its business operations, such as personal injury claims, employment matters, landlord-tenant disputes, patent claims and contractual disputes, some of which are covered by insurance. The Company believes its potential liability with respect to proceedings currently pending is not material, individually or in the aggregate, to the Company’s financial position, results of operations and cash flows.

Condensed Consolidating Financi

Condensed Consolidating Financial Information of Subsidiary Guarantors	3 Months Ended
	Mar. 31, 2016
Condensed Consolidating Financial Information of Subsidiary Guarantors	17. Condensed Consolidating Financial Information of Subsidiary Guarantors As of March 31, 2016, the Company had outstanding $400,000 aggregate principal amount of 5.125% senior notes due 2022, or the 5.125% Senior Notes and $755,000 aggregate principal amount of 4.875% senior notes due 2023, or the 4.875% Senior Notes (collectively the “Notes”). These Notes are fully and unconditionally guaranteed on a joint and several senior unsecured basis by the following subsidiaries of Cinemark USA, Inc.: Sunnymead Cinema Corp., Cinemark Properties, Inc., Greeley Holdings, Inc., Cinemark Partners I, Inc., CNMK Investments, Inc., CNMK Texas Properties, LLC., Cinemark Concessions LLC, Century Theatres, Inc., Marin Theatre Management, LLC, Century Theatres NG, LLC, Cinearts LLC, Cinearts Sacramento, LLC, Corte Madera Theatres, LLC, Novato Theatres, LLC, San Rafael Theatres, LLC, Northbay Theatres, LLC, Century Theatres Summit Sierra, LLC and Century Theatres Seattle, LLC. The following supplemental condensed consolidating financial information presents: a. Condensed consolidating balance sheet information as of December 31, 2015 and March 31, 2016, condensed consolidating statements of income information for the three months ended March 31, 2015 and 2016, condensed consolidating statements of comprehensive income (loss) information for the three months ended March 31, 2015 and 2016 and condensed consolidating statements of cash flows information for the three months ended March 31, 2015 and 2016. b. Cinemark USA, Inc. (the “Parent” and “Issuer”), combined Guarantor Subsidiaries and combined Non-Guarantor Subsidiaries with their investments in subsidiaries accounted for using the equity method of accounting and therefore, the Parent column reflects the equity income of its Guarantor Subsidiaries and Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Guarantor Subsidiaries and Non-Guarantor Subsidiaries column. Additionally, the Guarantor Subsidiaries column reflects the equity income (loss) of its Non-Guarantor Subsidiaries, which are also separately reflected in the stand-alone Non-Guarantor Subsidiaries column. c. Elimination entries necessary to consolidate the Parent and all of its Subsidiaries. CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 Other current assets 78,797 18,407 61,432 (32,024 ) 126,612 Accounts receivable from parent or subsidiaries 212,299 — — (211,128 ) 1,171 Total current assets 432,460 114,272 412,706 (243,152 ) 716,286 Theatre properties and equipment—net 539,082 614,821 351,166 — 1,505,069 Investment in subsidiaries 1,326,790 293,900 — (1,620,690 ) — Other assets 1,402,062 135,022 475,187 (105,994 ) 1,906,277 Total assets $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,405 $ — $ 8,405 Current portion of capital lease obligations 6,426 9,962 2,392 — 18,780 Accounts payable and accrued expenses 197,268 123,759 116,353 (25,396 ) 411,984 Accounts payable to parent or subsidiaries — 23,965 187,163 (211,128 ) — Total current liabilities 210,694 157,686 307,313 (236,524 ) 439,169 Long-term liabilities Long-term debt, less current portion 1,868,763 — 9,534 (105,367 ) 1,772,930 Capital lease obligations, less current portion 114,513 67,440 26,999 — 208,952 Other long-term liabilities and deferrals 404,278 77,774 118,533 (7,255 ) 593,330 Total long-term liabilities 2,387,554 145,214 155,066 (112,622 ) 2,575,212 Commitments and contingencies — — — — — Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,369 10,240 (467,609 ) 49,543 Other stockholder’s equity 1,052,603 397,746 755,335 (1,153,081 ) 1,052,603 Total Cinemark USA, Inc. stockholder’s equity 1,102,146 855,115 765,575 (1,620,690 ) 1,102,146 Noncontrolling interests — — 11,105 — 11,105 Total equity 1,102,146 855,115 776,680 (1,620,690 ) 1,113,251 Total liabilities and equity $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION March 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 95,068 $ 112,602 $ 376,139 $ — $ 583,809 Other current assets 73,279 19,031 57,970 (48,265 ) 102,015 Accounts receivable from parent or subsidiaries 248,023 — — (240,381 ) 7,642 Total current assets 416,370 131,633 434,109 (288,646 ) 693,466 Theatre properties and equipment—net 553,046 613,376 359,437 — 1,525,859 Investment in subsidiaries 1,399,149 307,978 — (1,707,127 ) — Other assets 1,406,884 134,583 478,142 (102,660 ) 1,916,949 Total assets $ 3,775,449 $ 1,187,570 $ 1,271,688 $ (2,098,433 ) $ 4,136,274 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,397 $ — $ 8,397 Current portion of capital lease obligations 6,625 9,575 2,641 — 18,841 Accounts payable and accrued expenses 208,802 87,233 97,152 (31,119 ) 362,068 Accounts payable to parent or subsidiaries — 47,201 193,180 (240,381 ) — Total current liabilities 222,427 144,009 294,370 (271,500 ) 389,306 Long-term liabilities Long-term debt, less current portion 1,889,740 — 9,534 (105,367 ) 1,793,907 Capital lease obligations, less current portion 112,862 65,285 28,221 — 206,368 Other long-term liabilities and deferrals 402,197 77,639 121,658 (14,439 ) 587,055 Total long-term liabilities 2,404,799 142,924 159,413 (119,806 ) 2,587,330 Commitments and contingencies — — — — — Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,368 10,239 (467,607 ) 49,543 Other stockholder’s equity 1,098,680 443,269 796,251 (1,239,520 ) 1,098,680 Total Cinemark USA, Inc. stockholder’s equity 1,148,223 900,637 806,490 (1,707,127 ) 1,148,223 Noncontrolling interests — — 11,415 — 11,415 Total equity 1,148,223 900,637 817,905 (1,707,127 ) 1,159,638 Total liabilities and equity $ 3,775,449 $ 1,187,570 $ 1,271,688 $ (2,098,433 ) $ 4,136,274 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION THREE MONTHS ENDED MARCH 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 216,573 $ 258,963 $ 180,207 $ (10,345 ) $ 645,398 Cost of operations Theatre operating expenses 176,282 178,234 128,188 (10,345 ) 472,359 General and administrative expenses 4,189 18,991 14,134 — 37,314 Depreciation and amortization 14,121 17,507 13,704 — 45,332 Impairment of long-lived assets 61 733 — — 794 (Gain) loss on sale of assets and other 1,415 (1,582 ) (1,283 ) — (1,450 ) Total cost of operations 196,068 213,883 154,743 (10,345 ) 554,349 Operating income 20,505 45,080 25,464 — 91,049 Other income (expense) Interest expense (25,249 ) (2,199 ) (775 ) 16 (28,207 ) Distributions from NCM 1,724 — 6,775 — 8,499 Equity in income of affiliates 45,085 11,615 5,200 (56,661 ) 5,239 Other income (expense) 46 11 (6,728 ) (16 ) (6,687 ) Total other income 21,606 9,427 4,472 (56,661 ) (21,156 ) Income before income taxes 42,111 54,507 29,936 (56,661 ) 69,893 Income taxes (790 ) 16,798 10,603 — 26,611 Net income 42,901 37,709 19,333 (56,661 ) 43,282 Less: Net income attributable to noncontrolling interests — — 381 — 381 Net income attributable to Cinemark USA, Inc. $ 42,901 $ 37,709 $ 18,952 $ (56,661 ) $ 42,901 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION THREE MONTHS ENDED MARCH 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 245,850 $ 297,397 $ 173,285 $ (11,663 ) $ 704,869 Cost of operations Theatre operating expenses 192,175 200,647 122,975 (11,663 ) 504,134 General and administrative expenses 3,462 23,949 9,701 — 37,112 Depreciation and amortization 16,494 19,639 13,196 — 49,329 Impairment of long-lived assets 136 — 356 — 492 (Gain) loss on sale of assets and other (1,753 ) (112 ) 86 — (1,779 ) Total cost of operations 210,514 244,123 146,314 (11,663 ) 589,288 Operating income 35,336 53,274 26,971 — 115,581 Other income (expense) Interest expense (25,168 ) (1,975 ) (1,217 ) 301 (28,059 ) Loss on early retirement of debt (13,186 ) — — — (13,186 ) Distributions from NCM 1,310 — 7,233 — 8,543 Equity in income of affiliates 59,592 16,706 6,897 (76,053 ) 7,142 Other income 78 3 3,458 (301 ) 3,238 Total other income 22,626 14,734 16,371 (76,053 ) (22,322 ) Income before income taxes 57,962 68,008 43,342 (76,053 ) 93,259 Income taxes (1,032 ) 19,863 14,913 — 33,744 Net income 58,994 48,145 28,429 (76,053 ) 59,515 Less: Net income attributable to noncontrolling interests — — 521 — 521 Net income attributable to Cinemark USA, Inc. $ 58,994 $ 48,145 $ 27,908 $ (76,053 ) $ 58,994 CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION THREE MONTHS ENDED MARCH 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 42,901 $ 37,709 $ 19,333 $ (56,661 ) $ 43,282 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $453 757 — — — 757 Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes of $444 766 — — — 766 Other comprehensive income of equity method investments 384 — 367 (367 ) 384 Foreign currency translation adjustments (46,681 ) — (46,675 ) 46,681 (46,675 ) Total other comprehensive loss, net of tax (44,774 ) — (46,308 ) 46,314 (44,768 ) Total comprehensive income (loss), net of tax $ (1,873 ) $ 37,709 $ (26,975 ) $ (10,347 ) $ (1,486 ) Comprehensive income attributable to noncontrolling interests — — (387 ) — (387 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ (1,873 ) $ 37,709 $ (27,362 ) $ (10,347 ) $ (1,873 ) CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION THREE MONTHS ENDED MARCH 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 58,994 $ 48,145 $ 28,429 $ (76,053 ) $ 59,515 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $118 201 — — — 201 Other comprehensive income of equity method investments (322 ) — (322 ) 322 (322 ) Foreign currency translation adjustments, net of taxes of $979 13,771 — 13,780 (13,771 ) 13,780 Total other comprehensive income, net of tax 13,650 — 13,458 (13,449 ) 13,659 Total comprehensive income, net of tax $ 72,644 $ 48,145 $ 41,887 $ (89,502 ) $ 73,174 Comprehensive income attributable to noncontrolling interests — — (530 ) — (530 ) Comprehensive income attributable to Cinemark USA, Inc. $ 72,644 $ 48,145 $ 41,357 $ (89,502 ) $ 72,644 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION THREE MONTHS ENDED MARCH 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 42,901 $ 37,709 $ 19,333 $ (56,661 ) $ 43,282 Adjustments to reconcile net income to cash provided by (used for) operating activities (46,642 ) 14,710 8,963 56,661 33,692 Changes in assets and liabilities and other (6,524 ) (30,303 ) (15,296 ) — (52,123 ) Net cash provided by (used for) operating activities (10,265 ) 22,116 13,000 — 24,851 Investing activities Additions to theatre properties and equipment and other (21,887 ) (51,329 ) (12,531 ) — (85,747 ) Acquisition of theatre in Brazil — — (2,651 ) — (2,651 ) Proceeds from sale of theatre properties and equipment and other 2 987 1,399 — 2,388 Investment in joint ventures and other — — (713 ) — (713 ) Net cash used for investing activities (21,885 ) (50,342 ) (14,496 ) — (86,723 ) Financing activities Dividends paid to parent (28,750 ) — — — (28,750 ) Repayments of long-term debt (1,750 ) — (8 ) — (1,758 ) Payments on capital leases (1,296 ) (2,168 ) (449 ) — (3,913 ) Other 2,244 (4,748 ) — — (2,504 ) Net cash used for financing activities (29,552 ) (6,916 ) (457 ) — (36,925 ) Effect of exchange rate changes on cash and cash equivalents — — (7,317 ) — (7,317 ) Decrease in cash and cash equivalents (61,702 ) (35,142 ) (9,270 ) — (106,114 ) Cash and cash equivalents: Beginning of year 129,505 77,645 431,691 — 638,841 End of year $ 67,803 $ 42,503 $ 422,421 $ — $ 532,727 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION THREE MONTHS ENDED MARCH 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 58,994 $ 48,145 $ 28,429 $ (76,053 ) $ 59,515 Adjustments to reconcile net income to cash provided by (used for) operating activities (51,423 ) 7,200 17,536 76,053 49,366 Changes in assets and liabilities (15,778 ) (12,740 ) (12,914 ) — (41,432 ) Net cash provided by (used for) operating activities (8,207 ) 42,605 33,051 — 67,449 Investing activities Additions to theatre properties and equipment (23,120 ) (18,022 ) (6,603 ) — (47,745 ) Proceeds from sale of theatre properties and equipment and other — 301 46 — 347 Acquisition of theatres in the US (15,300 ) — — — (15,300 ) Proceeds from sale of marketable securities 13,451 — — — 13,451 Dividends received from subsidiaries 433 5 — (438 ) — Investment in joint ventures and other — — (12 ) — (12 ) Net cash used for investing activities (24,536 ) (17,716 ) (6,569 ) (438 ) (49,259 ) Financing activities Dividends paid to parent (31,150 ) — (438 ) 438 (31,150 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — — (200,000 ) Repayments of long-term debt (1,750 ) — (8 ) — (1,758 ) Payments of debt issue costs (3,675 ) — — — (3,675 ) Payments on capital leases (1,451 ) (2,542 ) (579 ) — (4,572 ) Other 1,723 (5,610 ) (220 ) — (4,107 ) Net cash used for financing activities (13,553 ) (8,152 ) (1,245 ) 438 (22,512 ) Effect of exchange rate changes on cash and cash equivalents — — (372 ) — (372 ) Increase (decrease) in cash and cash equivalents (46,296 ) 16,737 24,865 — (4,694 ) Cash and cash equivalents: Beginning of year 141,364 95,865 351,274 — 588,503 End of year $ 95,068 $ 112,602 $ 376,139 $ — $ 583,809

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2016
Accounting Reclassifications	Accounting Reclassifications The Company has reclassified $8,049 in expenses from film rentals and advertising costs to utilities and other costs on the condensed consolidated statement of income for the three months ended March 31, 2015 to be consistent with the presentation for the three months ended March 31, 2016. During the three months ended March 31, 2016, the Company determined that reclassifying the expenses, which are related to the maintenance and monitoring of projection and sound equipment, results in a more clear presentation of film rental and advertising costs.

Equity (Tables)

Equity (Tables)	3 Months Ended
	Mar. 31, 2016
Summary of Changes in Stockholders' Equity	Below is a summary of changes in stockholders’ equity attributable to Cinemark USA, Inc., noncontrolling interests and total equity for the three months ended March 31, 2016 and 2015: Cinemark USA, Inc. Stockholder’s Noncontrolling Total Equity Interests Equity Balance at January 1, 2016 $ 1,102,146 $ 11,105 $ 1,113,251 Share based awards compensation expense 4,870 — 4,870 Tax benefit related to share based awards vesting 1,724 — 1,724 Cash dividends paid to parent (31,150 ) — (31,150 ) Dividends paid to noncontrolling interests — (220 ) (220 ) Net income 58,994 521 59,515 Fair value adjustments on interest rate swap agreements designated as hedges, net of settlements, net of taxes of $118 201 — 201 Gain realized on available-for-sale securities, net of taxes of $1,180 (2,011 ) — (2,011 ) Other comprehensive loss in equity method investees (322 ) — (322 ) Foreign currency translation adjustments 13,771 9 13,780 Balance at March 31, 2016 $ 1,148,223 $ 11,415 $ 1,159,638 Cinemark USA, Inc. Stockholder’s Noncontrolling Total Equity Interests Equity Balance at January 1, 2015 $ 1,126,394 $ 10,329 $ 1,136,723 Share based awards compensation expense 3,273 — 3,273 Tax benefit related to share based awards vesting 2,244 — 2,244 Cash and noncash dividends to parent (46,686 ) — (46,686 ) Net income 42,901 381 43,282 Fair value adjustments on interest rate swap agreements designated as hedges, net of settlements, net of taxes of $453 757 — 757 Fair value adjustments on available-for-sale securities, net of taxes of $444 766 — 766 Other comprehensive income in equity method investees 384 — 384 Foreign currency translation adjustments (46,681 ) 6 (46,675 ) Balance at March 31, 2015 $ 1,083,352 $ 10,716 $ 1,094,068

Investment in National CineMe27

Investment in National CineMedia (Tables)	3 Months Ended
	Mar. 31, 2016
NCM
Summary of Activity with NCM Included in Company's Condensed Consolidated Financial Statements	Below is a summary of activity with NCM included in the Company’s condensed consolidated financial statements: Distributions Investment Deferred from Equity in Other Cash in NCM Revenue NCM Income Revenue Received Balance as of January 1, 2016 $ 183,755 $ (342,134 ) Receipt of common units due to annual common unit adjustment 11,111 (11,111 ) $ — $ — $ — $ — Revenues earned under ESA (1) — — — — (2,806 ) 2,806 Receipt of excess cash distributions (5,321 ) — (5,602 ) — — 10,923 Receipt under tax receivable agreement (2,765 ) — (2,941 ) — — 5,706 Equity in earnings 1,873 — — (1,873 ) — — Amortization of deferred revenue — 2,223 — — (2,223 ) — Balance as of and for the three month period ended March 31, 2016 $ 188,653 $ (351,022 ) $ (8,543 ) $ (1,873 ) $ (5,029 ) $ 19,435 (1) Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company’s beverage concessionaire of approximately $2,586.

Other Investments (Tables)

Other Investments (Tables)	3 Months Ended
	Mar. 31, 2016
Other Investments	The Company had the following other investments at March 31, 2016: Digital Cinema Implementation Partners LLC (“DCIP”), equity method investment $ 75,690 AC JV, LLC, equity method investment 7,636 Digital Cinema Distribution Coalition (“DCDC”), equity method investment 3,043 Other 662 Total $ 87,031
Summary of Activity for Each of Investments	Below is a summary of activity for each of the investments for the three months ended March 31, 2016: DCIP RealD AC JV, DCDC Other Total Balance at January 1, 2016 $ 71,579 $ 12,900 $ 7,269 $ 2,562 $ 663 $ 94,973 Cash contributions 12 — — — — 12 Equity in income 4,421 — 367 481 — 5,269 Equity in comprehensive loss (322 ) — — — — (322 ) Sale of investment (1) — (12,900 ) — — — (12,900 ) Other — — — — (1 ) (1 ) Balance at March 31, 2016 $ 75,690 $ — $ 7,636 $ 3,043 $ 662 $ 87,031 (1) See further discussion of the sale of the investment held by the Company under RealD, Inc. below.
Transactions with DCIP	The Company had the following transactions, recorded in utilities and other on the condensed consolidated income statement, with DCIP during the three months ended March 31, 2016 and 2015: Three Months Ended 2016 2015 Equipment lease payments $ 1,125 $ 1,010 Warranty reimbursements from DCIP $ (1,324 ) $ (957 )
Digital Cinema Implementation Partners LLC
Summary of Financial Information	Below is summary financial information for DCIP for the three months ended March 31, 2016 and 2015: Three Months Ended March 31, 2016 March 31, 2015 Revenues $ 40,644 $ 40,741 Operating income $ 23,400 $ 23,764 Net income $ 18,502 $ 17,444
NCM
Summary of Financial Information	Below is summary financial information for NCM for the periods indicated: Quarter Ended Quarter Ended March 31, 2016 April 2, 2015 Gross revenues $ 76,242 $ 76,867 Operating income (loss) $ 5,751 $ (24,111 ) Net loss $ (7,510 ) $ (38,729 )

Share Based Awards (Tables)

Share Based Awards (Tables)	3 Months Ended
	Mar. 31, 2016
Summary of Restricted Stock Activity	Below is a summary of restricted stock activity for the three months ended March 31, 2016: Shares of Weighted Restricted Grant Date Stock Fair Value Outstanding at January 1, 2016 757,775 $ 30.73 Granted 269,214 $ 29.83 Vested (375,585 ) $ 24.70 Forfeited (30,170 ) $ 33.06 Outstanding at March 31, 2016 621,234 $ 33.86 Unvested restricted stock at March 31, 2016 621,234 $ 33.86
Number of Shares Vested Under Restricted Stock Unit Awards	Below is a table summarizing the potential number of shares that could vest under restricted stock unit awards granted during the three months ended March 31, 2016 at each of the three target levels of financial performance (excluding forfeiture assumptions): Number of Shares Value at Vesting Grant at IRR of at least 6.0% 84,554 $ 2,522 at IRR of at least 8.0% 169,107 $ 5,044 at IRR of at least 10.0% 253,661 $ 7,568
Restricted Stock Units (RSUs)
Summary of Restricted Stock Unit Award Activity	Three Months Ended March 31, 2016 2015 Number of restricted stock unit awards that vested during the period 143,872 123,769 Fair value of restricted stock unit awards that vested during the period $ 4,747 $ 5,501 Accumulated dividends paid upon vesting of restricted stock unit awards (1) $ 404 $ 46 Income tax benefit recognized upon vesting of restricted stock unit awards $ 1,993 $ 2,303 Compensation expense recognized during the period $ 2,217 $ 908 (1) Additional dividends of approximately $396 were paid during April 2015 related to the restricted stock unit awards that vested during the three months ended March 31, 2015.
Restricted Stock
Summary of Restricted Stock Award Activity	Three Months Ended March 31, 2016 2015 Compensation expense recognized during the period (1) $ 2,653 $ 2,365 Fair value of restricted shares that vested during the period $ 12,742 $ 13,161 Income tax deduction upon vesting of restricted stock awards $ 4,748 $ 3,311 (1) Cinemark Holdings, Inc. recorded an additional $248 and $225 of compensation expense related to these restricted stock awards during the quarters ended March 31, 2016 and 2015, respectively.

Interest Rate Swap Agreements (

Interest Rate Swap Agreements (Tables)	3 Months Ended
	Mar. 31, 2016
Interest Rate Swap Agreement Designated as Hedge Agreement	Below is a summary of the Company’s current interest rate swap agreement designated as a cash flow hedge as of March 31, 2016: Nominal Amount Effective Date Pay Rate Receive Rate Expiration Date Estimated Total Fair Value at March 31, 2016 (1) $ 100,000 November 2011 1.7150 % 1-Month LIBOR April 2016 $ 53 (1) Included in accounts payable and accrued expenses on the condensed consolidated balance sheet as of March 31, 2016.
Interest Rate Swap
Changes in Accumulated Other Comprehensive Loss, Net of Taxes, Related to Interest Rate Swap Agreements	The changes in accumulated other comprehensive loss, net of taxes, related to the Company’s interest rate swap agreements for the three months ended March 31, 2016 and 2015 were as follows: Interest Rate Swaps 2016 2015 Beginning balances – January 1 $ (234 ) $ (2,870 ) Other comprehensive loss before reclassifications, net of taxes (133 ) (689 ) Amounts reclassified from accumulated other comprehensive loss to interest expense, net of taxes 334 1,446 Net other comprehensive income 201 757 Ending balances – March 31 $ (33 ) $ (2,113 )

Goodwill and Other Intangible31

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2016
Summary of Goodwill	The Company’s goodwill was as follows: U.S. Operating Segment International Operating Segment Total Balance at January 1, 2016 (1) $ 1,156,556 $ 90,992 $ 1,247,548 Acquisition of U.S. theatres 8,350 — 8,350 Foreign currency translation adjustments — 2,788 2,788 Balance at March 31, 2016 (1) $ 1,164,906 $ 93,780 $ 1,258,686 (1) Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.
Intangible Assets	Intangible assets consisted of the following: Balance at Amortization Other (1) Balance at Intangible assets with finite lives: Gross carrying amount $ 99,968 $ — $ (642 ) $ 99,326 Accumulated amortization (59,706 ) (1,338 ) 661 (60,383 ) Total net intangible assets with finite lives $ 40,262 (1,338 ) 19 $ 38,943 Intangible assets with indefinite lives: Tradename 299,382 — 166 299,548 Total intangible assets — net $ 339,644 $ (1,338 ) $ 185 $ 338,491 (1) Includes non-compete agreement related to the acquisition of U.S. theatres, write-off of a fully amortized vendor contract, and foreign currency translation adjustments.
Estimated Aggregate Future Amortization Expense for Intangible Assets	Estimated aggregate future amortization expense for intangible assets is as follows: For the nine months ended December 31, 2016 $ 3,975 For the twelve months ended December 31, 2017 4,957 For the twelve months ended December 31, 2018 4,882 For the twelve months ended December 31, 2019 3,977 For the twelve months ended December 31, 2020 4,252 Thereafter 16,900 Total $ 38,943

Impairment of Long-Lived Asse32

Impairment of Long-Lived Assets (Tables)	3 Months Ended
	Mar. 31, 2016
Long-Lived Asset Impairment Losses	The long-lived asset impairment charges recorded during each of the periods presented are specific to theatres that were directly and individually impacted by increased competition, adverse changes in market demographics or adverse changes in the development or the conditions of the areas surrounding the theatre. Three Months Ended March 31, 2016 2015 United States theatre properties $ 136 $ 794 International theatre properties 356 — Impairment of long-lived assets $ 492 $ 794

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2016
Fair Value Measurement of Assets and Liabilities on Recurring Basis	Below is a summary of assets and liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of March 31, 2016: Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities – current (see Note 8) $ (53 ) $ — $ — $ (53 ) Below is a summary of assets and liabilities measured at fair value on a recurring basis by the Company under FASB ASC Topic 820 as of December 31, 2015: Carrying Fair Value Description Value Level 1 Level 2 Level 3 Interest rate swap liabilities – current (see Note 8) $ (373 ) $ — $ — $ (373 ) Investment in RealD (see Note 6) $ 12,900 $ 12,900 $ — $ —
Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value	Below is a reconciliation of the beginning and ending balance for liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3): Liabilities 2016 2015 Beginning balances —January 1 $ 373 $ 4,572 Total loss included in accumulated other comprehensive loss 14 236 Settlements (334 ) (1,446 ) Ending balances – March 31 $ 53 $ 3,362

Foreign Currency Translation (T

Foreign Currency Translation (Tables)	3 Months Ended
	Mar. 31, 2016
Summary of Impact of Translating Financial Statements of Certain of Company's International Subsidiaries	Below is a summary of the impact of translating the March 31, 2016 financial statements of the Company’s international subsidiaries: Other Comprehensive Income (Loss) for The Exchange Rate as of Three Months Ended Country March 31, 2016 December 31, 2015 March 31, 2016 Brazil 3.60 3.96 $ 18,298 Argentina 14.62 12.95 (7,151 ) Colombia 3,022.35 3,149.47 1,109 Chile 691.65 709.16 1,106 Peru 3.42 3.46 444 All other (35 ) $ 13,771

Supplemental Cash Flow Inform35

Supplemental Cash Flow Information (Tables)	3 Months Ended
	Mar. 31, 2016
Supplemental Information to Condensed Consolidated Statements of Cash Flows	The following is provided as supplemental information to the condensed consolidated statements of cash flows: Three Months Ended March 31, 2016 2015 Cash paid for interest $ 15,503 $ 11,358 Cash paid for income taxes, net of refunds received $ 6,259 $ 6,552 Noncash investing and financing activities: Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment (1) $ 3,055 $ 2,384 Theatre properties acquired under capital lease $ — $ 3,100 Investment in NCM – receipt of common units (see Note 5) $ 11,111 $ 15,421 Noncash dividends to Cinemark Holdings, Inc. $ — $ (17,936 ) (1) Additions to theatre properties and equipment included in accounts payable as of March 31, 2016 and December 31, 2015 were $14,209 and $11,154, respectively.

Segments (Tables)

Segments (Tables)	3 Months Ended
	Mar. 31, 2016
Selected Financial Information by Reportable Operating Segment	Below is a breakdown of selected financial information by reportable operating segment: Three Months Ended March 31, 2016 2015 Revenues U.S. $ 543,915 $ 474,295 International 164,175 174,333 Eliminations (3,221 ) (3,230 ) Total revenues $ 704,869 $ 645,398 Adjusted EBITDA (1) U.S. $ 144,139 $ 114,757 International 41,014 40,014 Total Adjusted EBITDA $ 185,153 $ 154,771 Capital expenditures U.S. $ 41,198 $ 74,267 International 6,547 11,480 Total capital expenditures $ 47,745 $ 85,747 (1) Distributions from equity method investees are reported entirely within the U.S. operating segment.
Reconciliation of Net Income to Adjusted EBITDA	The following table sets forth a reconciliation of net income to Adjusted EBITDA: Three Months Ended March 31, 2016 2015 Net income $ 59,515 $ 43,282 Add (deduct): Income taxes 33,744 26,611 Interest expense (1) 28,059 28,207 Other (income) expense (2) (10,380 ) 1,448 Loss on early retirement of debt 13,186 — Other cash distributions from equity investees (3) 8,086 7,264 Depreciation and amortization 49,329 45,332 Impairment of long-lived assets 492 794 Gain on sale of assets and other (1,779 ) (1,450 ) Deferred lease expenses (440 ) (703 ) Amortization of long-term prepaid rents 471 713 Share based awards compensation expense 4,870 3,273 Adjusted EBITDA $ 185,153 $ 154,771 (1) Includes amortization of debt issue costs. (2) Includes interest income, foreign currency exchange (gain) loss and equity in income of affiliates and excludes distributions from NCM. (3) Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow and for consistency with our peers, beginning with the three months ended March 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the three months ended March 31, 2015 has been recast to reflect comparable presentations.
Selected Financial Information by Geographic Area	Below is a breakdown of selected financial information by geographic area: Three Months Ended March 31, Revenues 2016 2015 U.S. $ 543,915 $ 474,295 Brazil 71,509 78,293 Other international countries 92,666 96,040 Eliminations (3,221 ) (3,230 ) Total $ 704,869 $ 645,398 Theatre Properties and Equipment-net March 31, 2016 December 31, 2015 U.S. $ 1,187,753 $ 1,175,535 Brazil 177,728 163,505 Other international countries 160,378 166,029 Total $ 1,525,859 $ 1,505,069

Condensed Consolidating Finan37

Condensed Consolidating Financial Information of Subsidiary Guarantors (Tables)	3 Months Ended
	Mar. 31, 2016
Condensed Consolidating Balance Sheet Information	CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION DECEMBER 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 141,364 $ 95,865 $ 351,274 $ — $ 588,503 Other current assets 78,797 18,407 61,432 (32,024 ) 126,612 Accounts receivable from parent or subsidiaries 212,299 — — (211,128 ) 1,171 Total current assets 432,460 114,272 412,706 (243,152 ) 716,286 Theatre properties and equipment—net 539,082 614,821 351,166 — 1,505,069 Investment in subsidiaries 1,326,790 293,900 — (1,620,690 ) — Other assets 1,402,062 135,022 475,187 (105,994 ) 1,906,277 Total assets $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,405 $ — $ 8,405 Current portion of capital lease obligations 6,426 9,962 2,392 — 18,780 Accounts payable and accrued expenses 197,268 123,759 116,353 (25,396 ) 411,984 Accounts payable to parent or subsidiaries — 23,965 187,163 (211,128 ) — Total current liabilities 210,694 157,686 307,313 (236,524 ) 439,169 Long-term liabilities Long-term debt, less current portion 1,868,763 — 9,534 (105,367 ) 1,772,930 Capital lease obligations, less current portion 114,513 67,440 26,999 — 208,952 Other long-term liabilities and deferrals 404,278 77,774 118,533 (7,255 ) 593,330 Total long-term liabilities 2,387,554 145,214 155,066 (112,622 ) 2,575,212 Commitments and contingencies — — — — — Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,369 10,240 (467,609 ) 49,543 Other stockholder’s equity 1,052,603 397,746 755,335 (1,153,081 ) 1,052,603 Total Cinemark USA, Inc. stockholder’s equity 1,102,146 855,115 765,575 (1,620,690 ) 1,102,146 Noncontrolling interests — — 11,105 — 11,105 Total equity 1,102,146 855,115 776,680 (1,620,690 ) 1,113,251 Total liabilities and equity $ 3,700,394 $ 1,158,015 $ 1,239,059 $ (1,969,836 ) $ 4,127,632 CONDENSED CONSOLIDATING BALANCE SHEET INFORMATION March 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Assets Current assets Cash and cash equivalents $ 95,068 $ 112,602 $ 376,139 $ — $ 583,809 Other current assets 73,279 19,031 57,970 (48,265 ) 102,015 Accounts receivable from parent or subsidiaries 248,023 — — (240,381 ) 7,642 Total current assets 416,370 131,633 434,109 (288,646 ) 693,466 Theatre properties and equipment—net 553,046 613,376 359,437 — 1,525,859 Investment in subsidiaries 1,399,149 307,978 — (1,707,127 ) — Other assets 1,406,884 134,583 478,142 (102,660 ) 1,916,949 Total assets $ 3,775,449 $ 1,187,570 $ 1,271,688 $ (2,098,433 ) $ 4,136,274 Liabilities and equity Current liabilities Current portion of long-term debt $ 7,000 $ — $ 1,397 $ — $ 8,397 Current portion of capital lease obligations 6,625 9,575 2,641 — 18,841 Accounts payable and accrued expenses 208,802 87,233 97,152 (31,119 ) 362,068 Accounts payable to parent or subsidiaries — 47,201 193,180 (240,381 ) — Total current liabilities 222,427 144,009 294,370 (271,500 ) 389,306 Long-term liabilities Long-term debt, less current portion 1,889,740 — 9,534 (105,367 ) 1,793,907 Capital lease obligations, less current portion 112,862 65,285 28,221 — 206,368 Other long-term liabilities and deferrals 402,197 77,639 121,658 (14,439 ) 587,055 Total long-term liabilities 2,404,799 142,924 159,413 (119,806 ) 2,587,330 Commitments and contingencies — — — — — Equity Cinemark USA, Inc.’s stockholder’s equity: Common stock 49,543 457,368 10,239 (467,607 ) 49,543 Other stockholder’s equity 1,098,680 443,269 796,251 (1,239,520 ) 1,098,680 Total Cinemark USA, Inc. stockholder’s equity 1,148,223 900,637 806,490 (1,707,127 ) 1,148,223 Noncontrolling interests — — 11,415 — 11,415 Total equity 1,148,223 900,637 817,905 (1,707,127 ) 1,159,638 Total liabilities and equity $ 3,775,449 $ 1,187,570 $ 1,271,688 $ (2,098,433 ) $ 4,136,274
Condensed Consolidating Statement of Income Information	CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION THREE MONTHS ENDED MARCH 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 216,573 $ 258,963 $ 180,207 $ (10,345 ) $ 645,398 Cost of operations Theatre operating expenses 176,282 178,234 128,188 (10,345 ) 472,359 General and administrative expenses 4,189 18,991 14,134 — 37,314 Depreciation and amortization 14,121 17,507 13,704 — 45,332 Impairment of long-lived assets 61 733 — — 794 (Gain) loss on sale of assets and other 1,415 (1,582 ) (1,283 ) — (1,450 ) Total cost of operations 196,068 213,883 154,743 (10,345 ) 554,349 Operating income 20,505 45,080 25,464 — 91,049 Other income (expense) Interest expense (25,249 ) (2,199 ) (775 ) 16 (28,207 ) Distributions from NCM 1,724 — 6,775 — 8,499 Equity in income of affiliates 45,085 11,615 5,200 (56,661 ) 5,239 Other income (expense) 46 11 (6,728 ) (16 ) (6,687 ) Total other income 21,606 9,427 4,472 (56,661 ) (21,156 ) Income before income taxes 42,111 54,507 29,936 (56,661 ) 69,893 Income taxes (790 ) 16,798 10,603 — 26,611 Net income 42,901 37,709 19,333 (56,661 ) 43,282 Less: Net income attributable to noncontrolling interests — — 381 — 381 Net income attributable to Cinemark USA, Inc. $ 42,901 $ 37,709 $ 18,952 $ (56,661 ) $ 42,901 CONDENSED CONSOLIDATING STATEMENT OF INCOME INFORMATION THREE MONTHS ENDED MARCH 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Revenues $ 245,850 $ 297,397 $ 173,285 $ (11,663 ) $ 704,869 Cost of operations Theatre operating expenses 192,175 200,647 122,975 (11,663 ) 504,134 General and administrative expenses 3,462 23,949 9,701 — 37,112 Depreciation and amortization 16,494 19,639 13,196 — 49,329 Impairment of long-lived assets 136 — 356 — 492 (Gain) loss on sale of assets and other (1,753 ) (112 ) 86 — (1,779 ) Total cost of operations 210,514 244,123 146,314 (11,663 ) 589,288 Operating income 35,336 53,274 26,971 — 115,581 Other income (expense) Interest expense (25,168 ) (1,975 ) (1,217 ) 301 (28,059 ) Loss on early retirement of debt (13,186 ) — — — (13,186 ) Distributions from NCM 1,310 — 7,233 — 8,543 Equity in income of affiliates 59,592 16,706 6,897 (76,053 ) 7,142 Other income 78 3 3,458 (301 ) 3,238 Total other income 22,626 14,734 16,371 (76,053 ) (22,322 ) Income before income taxes 57,962 68,008 43,342 (76,053 ) 93,259 Income taxes (1,032 ) 19,863 14,913 — 33,744 Net income 58,994 48,145 28,429 (76,053 ) 59,515 Less: Net income attributable to noncontrolling interests — — 521 — 521 Net income attributable to Cinemark USA, Inc. $ 58,994 $ 48,145 $ 27,908 $ (76,053 ) $ 58,994
Condensed Consolidating Statement of Comprehensive Income (Loss) Information	CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME (LOSS) INFORMATION THREE MONTHS ENDED MARCH 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 42,901 $ 37,709 $ 19,333 $ (56,661 ) $ 43,282 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $453 757 — — — 757 Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes of $444 766 — — — 766 Other comprehensive income of equity method investments 384 — 367 (367 ) 384 Foreign currency translation adjustments (46,681 ) — (46,675 ) 46,681 (46,675 ) Total other comprehensive loss, net of tax (44,774 ) — (46,308 ) 46,314 (44,768 ) Total comprehensive income (loss), net of tax $ (1,873 ) $ 37,709 $ (26,975 ) $ (10,347 ) $ (1,486 ) Comprehensive income attributable to noncontrolling interests — — (387 ) — (387 ) Comprehensive income (loss) attributable to Cinemark USA, Inc. $ (1,873 ) $ 37,709 $ (27,362 ) $ (10,347 ) $ (1,873 ) CONDENSED CONSOLIDATING STATEMENT OF COMPREHENSIVE INCOME INFORMATION THREE MONTHS ENDED MARCH 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Net income $ 58,994 $ 48,145 $ 28,429 $ (76,053 ) $ 59,515 Other comprehensive income (loss), net of tax Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes of $118 201 — — — 201 Other comprehensive income of equity method investments (322 ) — (322 ) 322 (322 ) Foreign currency translation adjustments, net of taxes of $979 13,771 — 13,780 (13,771 ) 13,780 Total other comprehensive income, net of tax 13,650 — 13,458 (13,449 ) 13,659 Total comprehensive income, net of tax $ 72,644 $ 48,145 $ 41,887 $ (89,502 ) $ 73,174 Comprehensive income attributable to noncontrolling interests — — (530 ) — (530 ) Comprehensive income attributable to Cinemark USA, Inc. $ 72,644 $ 48,145 $ 41,357 $ (89,502 ) $ 72,644
Condensed Consolidating Statement of Cash Flows Information	CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION THREE MONTHS ENDED MARCH 31, 2015 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 42,901 $ 37,709 $ 19,333 $ (56,661 ) $ 43,282 Adjustments to reconcile net income to cash provided by (used for) operating activities (46,642 ) 14,710 8,963 56,661 33,692 Changes in assets and liabilities and other (6,524 ) (30,303 ) (15,296 ) — (52,123 ) Net cash provided by (used for) operating activities (10,265 ) 22,116 13,000 — 24,851 Investing activities Additions to theatre properties and equipment and other (21,887 ) (51,329 ) (12,531 ) — (85,747 ) Acquisition of theatre in Brazil — — (2,651 ) — (2,651 ) Proceeds from sale of theatre properties and equipment and other 2 987 1,399 — 2,388 Investment in joint ventures and other — — (713 ) — (713 ) Net cash used for investing activities (21,885 ) (50,342 ) (14,496 ) — (86,723 ) Financing activities Dividends paid to parent (28,750 ) — — — (28,750 ) Repayments of long-term debt (1,750 ) — (8 ) — (1,758 ) Payments on capital leases (1,296 ) (2,168 ) (449 ) — (3,913 ) Other 2,244 (4,748 ) — — (2,504 ) Net cash used for financing activities (29,552 ) (6,916 ) (457 ) — (36,925 ) Effect of exchange rate changes on cash and cash equivalents — — (7,317 ) — (7,317 ) Decrease in cash and cash equivalents (61,702 ) (35,142 ) (9,270 ) — (106,114 ) Cash and cash equivalents: Beginning of year 129,505 77,645 431,691 — 638,841 End of year $ 67,803 $ 42,503 $ 422,421 $ — $ 532,727 CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS INFORMATION THREE MONTHS ENDED MARCH 31, 2016 Parent Subsidiary Subsidiary Company Guarantors Non-Guarantors Eliminations Consolidated (In thousands) Operating activities Net income $ 58,994 $ 48,145 $ 28,429 $ (76,053 ) $ 59,515 Adjustments to reconcile net income to cash provided by (used for) operating activities (51,423 ) 7,200 17,536 76,053 49,366 Changes in assets and liabilities (15,778 ) (12,740 ) (12,914 ) — (41,432 ) Net cash provided by (used for) operating activities (8,207 ) 42,605 33,051 — 67,449 Investing activities Additions to theatre properties and equipment (23,120 ) (18,022 ) (6,603 ) — (47,745 ) Proceeds from sale of theatre properties and equipment and other — 301 46 — 347 Acquisition of theatres in the US (15,300 ) — — — (15,300 ) Proceeds from sale of marketable securities 13,451 — — — 13,451 Dividends received from subsidiaries 433 5 — (438 ) — Investment in joint ventures and other — — (12 ) — (12 ) Net cash used for investing activities (24,536 ) (17,716 ) (6,569 ) (438 ) (49,259 ) Financing activities Dividends paid to parent (31,150 ) — (438 ) 438 (31,150 ) Proceeds from issuance of Senior Notes, net of discount 222,750 — — — 222,750 Retirement of Senior Subordinated Notes (200,000 ) — — — (200,000 ) Repayments of long-term debt (1,750 ) — (8 ) — (1,758 ) Payments of debt issue costs (3,675 ) — — — (3,675 ) Payments on capital leases (1,451 ) (2,542 ) (579 ) — (4,572 ) Other 1,723 (5,610 ) (220 ) — (4,107 ) Net cash used for financing activities (13,553 ) (8,152 ) (1,245 ) 438 (22,512 ) Effect of exchange rate changes on cash and cash equivalents — — (372 ) — (372 ) Increase (decrease) in cash and cash equivalents (46,296 ) 16,737 24,865 — (4,694 ) Cash and cash equivalents: Beginning of year 141,364 95,865 351,274 — 588,503 End of year $ 95,068 $ 112,602 $ 376,139 $ — $ 583,809

The Company and Basis of Pres38

The Company and Basis of Presentation - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Summary Of Significant Accounting Policies [Line Items]
Film rentals and advertising costs	$ 232,914	$ 207,610
Utilities and other costs	$ 81,377	83,406
Scenario, Previously Reported
Summary Of Significant Accounting Policies [Line Items]
Film rentals and advertising costs		8,049
Restatement Adjustment
Summary Of Significant Accounting Policies [Line Items]
Utilities and other costs		$ 8,049

Long Term Debt Activity - Addit

Long Term Debt Activity - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 21, 2016	Mar. 31, 2016	Dec. 31, 2015
Debt Instrument [Line Items]
Principal amount redeemed		$ 200,000
Write off of unamortization of debt issuance cost		2,369
Loss on early retirement of debt		13,186
Carrying value of long-term debt		1,837,814	$ 1,814,572
Fair value of long-term debt		1,854,540	$ 1,806,276
4.875 % Senior Notes Due May 2023
Debt Instrument [Line Items]
Aggregate principal amount issued	$ 225,000	$ 755,000
Interest rate	4.875%	4.875%
Price to repurchase the senior subordinated notes as a percentage of the aggregate principal amount outstanding plus accrued and unpaid interest in case of change of control	99.00%
Debt instrument, maturity date		Jun. 1, 2023
Debt issuance costs		$ 3,656
Debt issue costs,discount		$ 2,250
7.375% Senior Subordinated Notes Due 2021
Debt Instrument [Line Items]
Interest rate	7.375%
Maturity year	2,021
Principal amount redeemed	$ 200,000
Percentage of debt repayment premium	104.00%
Write off of unamortization of debt issuance cost	$ 2,369
Early retirement of debt	9,670
Loss on early retirement of debt	$ 1,147

Summary of Changes in Stockhold

Summary of Changes in Stockholders' Equity (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Shareholders Equity [Line Items]
Total Equity, Beginning Balance	$ 1,113,251	$ 1,136,723
Cinemark USA, Inc. stockholder's equity, Beginning Balance	1,102,146
Noncontrolling Interests, Beginning Balance	11,105
Share based awards compensation expense	4,870	3,273
Tax benefit related to share based awards vesting	1,724	2,244
Cash and noncash dividends to parent	(31,150)	(46,686)
Dividends paid to noncontrolling interests	(220)
Net income	59,515	43,282
Net income attributable to Cinemark USA, Inc.	58,994	42,901
Net income attributable to Noncontrolling Interests	(521)	(381)
Noncontrolling Interests, Ending Balance	11,415
Fair value adjustments on interest rate swap agreements designated as hedges, net of settlements, net of taxes	201	757
Gain realized on available-for-sale securities, net of taxes of $1,180	(2,011)
Fair value adjustments on available-for-sale securities, net of taxes		766
Other comprehensive income (loss) in equity method investees	(322)	384
Foreign currency translation adjustments	13,780	(46,675)
Total Equity, Ending Balance	1,159,638	1,094,068
Cinemark USA, Inc. stockholder's equity, Ending Balance	1,148,223
Cinemark USA, Inc. Stockholder's Equity
Shareholders Equity [Line Items]
Cinemark USA, Inc. stockholder's equity, Beginning Balance	1,102,146	1,126,394
Share based awards compensation expense	4,870	3,273
Tax benefit related to share based awards vesting	1,724
Tax benefit related to share based awards vesting		2,244
Cash and noncash dividends to parent		(46,686)
Cash dividends paid to parent	(31,150)
Net income attributable to Cinemark USA, Inc.	58,994	42,901
Fair value adjustments on interest rate swap agreements designated as hedges, net of settlements, net of taxes	201	757
Gain realized on available-for-sale securities, net of taxes of $1,180	(2,011)
Fair value adjustments on available-for-sale securities, net of taxes		766
Other comprehensive income (loss) in equity method investees	(322)	384
Foreign currency translation adjustments attributable to Cinemark USA, Inc.	13,771	(46,681)
Cinemark USA, Inc. stockholder's equity, Ending Balance	1,148,223	1,083,352
Noncontrolling Interest
Shareholders Equity [Line Items]
Noncontrolling Interests, Beginning Balance	11,105	10,329
Dividends paid to noncontrolling interests	(220)
Net income attributable to Noncontrolling Interests	521	381
Foreign currency translation adjustments attributable to Noncontrolling Interests	9	6
Noncontrolling Interests, Ending Balance	$ 11,415	$ 10,716

Summary of Changes in Stockho41

Summary of Changes in Stockholders' Equity (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Shareholders Equity [Line Items]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	$ 118	$ 453
Gain realized on available-for-sale securities, taxes	1,180
Unrealized (loss) gain due to fair value adjustments on available-for-sale securities, taxes		444
Cinemark USA, Inc. Stockholder's Equity
Shareholders Equity [Line Items]
Unrealized loss due to fair value adjustments on interest rate swap agreements, taxes	118	453
Gain realized on available-for-sale securities, taxes	$ 1,180
Unrealized (loss) gain due to fair value adjustments on available-for-sale securities, taxes		$ 444

Summary of Activity with NCM In

Summary of Activity with NCM Included in Company's Condensed Consolidated Financial Statements (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Schedule of Equity Method Investments [Line Items]
Equity in earnings		$ (7,142)	$ (5,239)
NCM
Schedule of Equity Method Investments [Line Items]
Beginning Balance		183,755
Equity in earnings		(1,873)	$ (795)
Ending Balance		188,653
Beginning Balance		(342,134)
Ending Balance		(351,022)
Cash Received
Schedule of Equity Method Investments [Line Items]
Receipt of excess cash distributions		10,923
Receipt under tax receivable agreement		5,706
Revenues earned under ESA	[1]	2,806
Ending Balance		19,435
Other Revenue
Schedule of Equity Method Investments [Line Items]
Revenues earned under ESA	[1]	2,806
Ending Balance		(5,029)
Other Revenue | NCM
Schedule of Equity Method Investments [Line Items]
Amortization of deferred revenue		(2,223)
Equity In Income
Schedule of Equity Method Investments [Line Items]
Ending Balance		(1,873)
Equity In Income | NCM
Schedule of Equity Method Investments [Line Items]
Equity in earnings		(1,873)
Distributions from NCM
Schedule of Equity Method Investments [Line Items]
Receipt of excess cash distributions		(5,602)
Receipt under tax receivable agreement		(2,941)
Ending Balance		(8,543)
Investment In NCM
Schedule of Equity Method Investments [Line Items]
Beginning Balance		183,755
Receipt of common units due to annual common unit adjustment		11,111
Receipt of excess cash distributions		(5,321)
Receipt under tax receivable agreement		(2,765)
Equity in earnings		1,873
Ending Balance		188,653
Deferred Revenue
Schedule of Equity Method Investments [Line Items]
Receipt of common units due to annual common unit adjustment		(11,111)
Beginning Balance		(342,134)
Ending Balance		(351,022)
Deferred Revenue | NCM
Schedule of Equity Method Investments [Line Items]
Amortization of deferred revenue		$ 2,223
[1]	Amount includes the per patron and per digital screen theatre access fees due to the Company, net of amounts due to NCM for on-screen advertising time provided to the Company's beverage concessionaire of approximately $2,586.

Summary of Activity with NCM 43

Summary of Activity with NCM Included in Company's Condensed Consolidated Financial Statements (Parenthetical) (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)
Schedule of Equity Method Investments [Line Items]
Company's beverage concessionaire advertising costs	$ 2,586

Investment in National CineMe44

Investment in National CineMedia - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Schedule of Equity Method Investments [Line Items]
Equity in earnings	$ 7,142	$ 5,239
Number of additional common units of NCM received under common unit adjustment agreement	753,598
Value of common units received from NCM	$ 11,111	15,421
Remaining term of exhibitor services agreement	20 years
Number of common units of NCM owned by Company	26,384,644
Interest in common units of NCM owned by Company	19.00%
Investment In NCM
Schedule of Equity Method Investments [Line Items]
Equity in earnings	$ (1,873)
Estimated fair value of investment using NCMI's stock price	$ 401,310
NCMI stock price	$ 15.21
NCM
Schedule of Equity Method Investments [Line Items]
Equity in earnings	$ 1,873	795
NCM | Theatre Properties and Equipment
Schedule of Equity Method Investments [Line Items]
Payment for installation of certain equipment used for digital advertising	$ 22	$ 20

Summary Financial Information f

Summary Financial Information for National CineMedia (Detail) - NCM - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Apr. 02, 2015
Schedule of Equity Method Investments [Line Items]
Revenues	$ 76,242	$ 76,867
Operating income (loss)	5,751	(24,111)
Net loss	$ (7,510)	$ (38,729)

Other Investments (Detail)

Other Investments (Detail) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	$ 87,031	$ 94,973
Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	87,031	94,973
Digital Cinema Implementation Partners LLC | Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	75,690	71,579
AC JV, LLC | Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	7,636	7,269
Digital Cinema Distribution Coalition | Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	3,043	2,562
Other Investment | Other Affiliates
Investments in and Advances to Affiliates [Line Items]
Investments in and advances to affiliates	$ 662	$ 663

Summary of Activity for Each of

Summary of Activity for Each of Investment (Detail) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended
		Dec. 31, 2013	Mar. 31, 2016	Mar. 31, 2015
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			$ 94,973
Equity in earnings			(7,142)	$ (5,239)
Equity in comprehensive loss			322	$ (384)
Investments, ending balance			87,031
Other Affiliates
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			94,973
Cash contributions			12
Equity in earnings			5,269
Equity in comprehensive loss			(322)
Sale of investment	[1]		(12,900)
Other			(1)
Investments, ending balance			87,031
Other Affiliates | Digital Cinema Implementation Partners LLC
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			71,579
Cash contributions			12
Equity in earnings			4,421
Equity in comprehensive loss			(322)
Other			0
Investments, ending balance			75,690
Other Affiliates | RealD
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			12,900
Cash contributions			0
Equity in earnings			0
Equity in comprehensive loss			0
Sale of investment	[1]		(12,900)
Other			0
Investments, ending balance			0
Other Affiliates | AC JV, LLC
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			7,269
Cash contributions		$ 268	0
Equity in earnings			367
Equity in comprehensive loss			0
Other			0
Investments, ending balance			7,636
Other Affiliates | Digital Cinema Distribution Coalition
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			2,562
Cash contributions			0
Equity in earnings			481
Equity in comprehensive loss			0
Other			0
Investments, ending balance			3,043
Other Affiliates | Other Investment
Schedule of Equity Method Investments [Line Items]
Investments, beginning balance			663
Cash contributions			0
Equity in earnings			0
Equity in comprehensive loss			0
Other			(1)
Investments, ending balance			$ 662
[1]	See further discussion of the sale of the investment held by the Company under RealD, Inc. below.

Other Investments - Additional

Other Investments - Additional Information (Detail) $ / shares in Units, $ in Thousands	Mar. 22, 2016USD ($)$ / shares	Dec. 31, 2013USD ($)	Mar. 31, 2011$ / shares	Mar. 31, 2016USD ($)ProjectionSystem	Mar. 31, 2015USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2011shares
Schedule of Equity Method Investments [Line Items]
Number of shares owned in RealD | shares							1,222,780
Exercise price of options, shares | $ / shares			$ 0.00667
Other Affiliates
Schedule of Equity Method Investments [Line Items]
Cash contributions				$ 12
Other Affiliates | Digital Cinema Implementation Partners LLC
Schedule of Equity Method Investments [Line Items]
Percentage of voting interest				33.00%
Economic interest in Digital Cinema Implementation Partners				24.30%
Number of equipment being leased under master equipment lease agreement | ProjectionSystem				3,781
Cash contributions				$ 12
Other Affiliates | RealD
Schedule of Equity Method Investments [Line Items]
Purchase price per share | $ / shares	$ 11
Gain on investment				3,742
Unrealized holding gain previously recorded in AOCI				3,191
Investments shares sold	$ 13,451
Cash contributions				0
Other Affiliates | RealD | Utilities and other
Schedule of Equity Method Investments [Line Items]
Licensing fees				1,895	$ 1,156
Other Affiliates | AC JV, LLC
Schedule of Equity Method Investments [Line Items]
Ownership of class A units sold to Founding Members		97.00%
Cash contributions		$ 268		0
Ownership of class A units		1.00%
Ownership of class A units						31.00%
Aggregate value of Class A units						$ 25,000
Promissory note term						6 years
Original principal value of promissory note with NCM						$ 8,333
Annual Interest rate on promissory note		5.00%				5.00%
Remaining outstanding balance of note payable				5,555
Other Affiliates | AC JV, LLC | Film rentals and advertising
Schedule of Equity Method Investments [Line Items]
Event fees				$ 2,930	3,401
Other Affiliates | Digital Cinema Distribution Coalition
Schedule of Equity Method Investments [Line Items]
Percentage of voting interest				14.60%
Cash contributions				$ 0
Payments for content delivery services				$ 307	$ 208

Summary Financial Information49

Summary Financial Information for DCIP (Detail) - Digital Cinema Implementation Partners LLC - Other Affiliates - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Schedule of Equity Method Investments [Line Items]
Revenues	$ 40,644	$ 40,741
Operating income	23,400	23,764
Net income	$ 18,502	$ 17,444

Transactions with DCIP (Detail)

Transactions with DCIP (Detail) - Other Affiliates - Digital Cinema Implementation Partners LLC - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Schedule of Equity Method Investments [Line Items]
Equipment lease payments	$ 1,125	$ 1,010
Warranty reimbursements from DCIP	$ (1,324)	$ (957)

Share Based Awards - Additional

Share Based Awards - Additional Information (Detail) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)$ / sharesshares
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares of Restricted Stock, Granted | shares	269,214
Market value of common stock on the date of grant | $ / shares	$ 29.83
Minimum forfeiture rate for restricted stock awards	0.00%
Maximum forfeiture rate for restricted stock awards	8.00%
Unrecognized Compensation expense	$ 16,277
Compensation Expense recognition period (in years)	3 years
Restricted Stock | Minimum | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period for restricted stock granted	1 month
Restricted Stock | Maximum | Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period for restricted stock granted	4 years
Restricted Stock | Cinemark USA Inc
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation expense	$ 16,070
Restricted Stock | Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation expense	$ 207
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Market value of common stock on the date of grant | $ / shares	$ 29.83
Unrecognized Compensation expense	$ 8,492
Compensation Expense recognition period (in years)	2 years
Number of hypothetical shares of common stock issued to employees | shares	253,661
Percentage of IRR, which is the threshold	6.00%
Percentage of IRR, which is the target	8.00%
Percentage of IRR, which is the maximum	10.00%
Percentage of restricted stock units vest	100.00%
Percentage of IRR expected	9.00%
Number of hypothetical shares of common stock at assumed IRR level | shares	643,400
Actual cumulative forfeitures (in units) | shares	17,917
Incremental share based award compensation expense	$ 994
Restricted Stock Units (RSUs) | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected forfeiture rate	0.00%
Restricted Stock Units (RSUs) | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected forfeiture rate	10.00%

Summary of Restricted Stock Act

Summary of Restricted Stock Activity (Detail) - Restricted Stock	3 Months Ended
	Mar. 31, 2016$ / sharesshares
Shares of Restricted Stock
Shares of Restricted Stock, Beginning balance | shares	757,775
Shares of Restricted Stock, Granted | shares	269,214
Shares of Restricted Stock, Vested | shares	(375,585)
Shares of Restricted Stock, Forfeited | shares	(30,170)
Shares of Restricted Stock, Ending balance | shares	621,234
Shares of Restricted Stock, Unvested restricted stock | shares	621,234
Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value Outstanding, Beginning | $ / shares	$ 30.73
Weighted Average Grant Date Fair Value, Granted | $ / shares	29.83
Weighted Average Grant Date Fair Value, Vested | $ / shares	24.70
Weighted Average Grant Date Fair Value, Forfeited | $ / shares	33.06
Weighted Average Grant Date Fair Value Outstanding, Ending | $ / shares	33.86
Weighted Average Grant Date Fair Value, Unvested restricted stock | $ / shares	$ 33.86

Summary of Restricted Stock Awa

Summary of Restricted Stock Award Activity (Detail) - Restricted Stock - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized during the period	[1]	$ 2,653	$ 2,365
Fair value of share based awards that vested during the period		12,742	13,161
Income tax benefit recognized upon vesting of share based awards		$ 4,748	$ 3,311
[1]	Cinemark Holdings, Inc. recorded an additional $248 and $225 of compensation expense related to these restricted stock awards during the quarters ended March 31, 2016 and 2015, respectively.

Summary of Restricted Stock A54

Summary of Restricted Stock Award Activity (Parenthetical) (Detail) - Restricted Stock - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period	[1]	$ 2,653	$ 2,365
Cinemark Holdings, Inc.
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized by the Company during the period		$ 248	$ 225
[1]	Cinemark Holdings, Inc. recorded an additional $248 and $225 of compensation expense related to these restricted stock awards during the quarters ended March 31, 2016 and 2015, respectively.

Summary of Potential Number of

Summary of Potential Number of Shares Vesting under Restricted Stock Unit Awards (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)shares
Schedule of Restricted Stock Unit [Line Items]
Number of shares vesting at IRR of at least 6.0% | shares	84,554
Number of shares vesting at IRR of at least 8.0% | shares	169,107
Number of shares vesting at IRR of at least 10.0% | shares	253,661
Value at grant at IRR of at least 6.0% | $	$ 2,522
Value at grant at IRR of at least 8.0% | $	5,044
Value at grant at IRR of at least 10.0% | $	$ 7,568

Summary of Restricted Stock Uni

Summary of Restricted Stock Unit Award Activity (Detail) - Restricted Stock Units (RSUs) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Apr. 30, 2015	Mar. 31, 2016		Mar. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of restricted stock unit awards that vested during the period		143,872		123,769
Fair value of share based awards that vested during the period		$ 4,747		$ 5,501
Accumulated dividends paid upon vesting of restricted stock unit awards	$ 396	404	[1]	46	[1]
Income tax benefit recognized upon vesting of share based awards		1,993		2,303
Compensation expense recognized during the period		$ 2,217		$ 908
[1]	Additional dividends of approximately $396 were paid during April 2015 related to the restricted stock unit awards that vested during the three months ended March 31, 2015.

Summary of Restricted Stock U57

Summary of Restricted Stock Unit Award Activity (Parenthetical) (Detail) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended
	Apr. 30, 2015	Mar. 31, 2016		Mar. 31, 2015
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Accumulated dividends paid	$ 396	$ 404	[1]	$ 46	[1]
[1]	Additional dividends of approximately $396 were paid during April 2015 related to the restricted stock unit awards that vested during the three months ended March 31, 2015.

Interest Rate Swap Agreement -

Interest Rate Swap Agreement - Additional Information (Detail)	Mar. 31, 2016Agreement
Derivative [Line Items]
Number of interest rate swap agreements	1

Summary of Interest Rate Swap A

Summary of Interest Rate Swap Agreement Designated as Hedge Agreement (Detail) - Interest Rate Swap $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)
Interest Rate Swaps [Line Items]
Nominal Amount	$ 100,000
Effective Date	Nov. 1, 2011
Pay Rate	1.715%
Receive Rate	1-Month LIBOR
Expiration Date	Apr. 1, 2016
Estimated Total Fair Value at March 31, 2016	$ 53	[1]
[1]	Included in accounts payable and accrued expenses on the condensed consolidated balance sheet as of March 31, 2016.

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Loss, Net of Taxes, Related to Interest Rate Swap Agreements (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other comprehensive income (loss) before reclassifications, net of taxes	$ 201	$ 757
Net other comprehensive income	201	757
Interest Rate Swap
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning balances	(234)	(2,870)
Other comprehensive income (loss) before reclassifications, net of taxes	(133)	(689)
Amounts reclassified from accumulated other comprehensive loss to interest expense, net of taxes	334	1,446
Net other comprehensive income	201	757
Ending balances	$ (33)	$ (2,113)

Summary of Goodwill (Detail)

Summary of Goodwill (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)
Goodwill [Line Items]
Beginning Balance	$ 1,247,548	[1]
Acquisitions of theatres	8,350
Foreign currency translation adjustments	2,788
Ending Balance	1,258,686	[1]
U.S. Operating Segment
Goodwill [Line Items]
Beginning Balance	1,156,556	[1]
Acquisitions of theatres	8,350
Ending Balance	1,164,906	[1]
International Operating Segment
Goodwill [Line Items]
Beginning Balance	90,992	[1]
Foreign currency translation adjustments	2,788
Ending Balance	$ 93,780	[1]
[1]	Balances are presented net of accumulated impairment losses of $214,031 for the U.S. operating segment and $27,622 for the international operating segment.

Summary of Goodwill (Parentheti

Summary of Goodwill (Parenthetical) (Detail) $ in Thousands	Mar. 31, 2016USD ($)
U.S. Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 214,031
International Operating Segment
Goodwill [Line Items]
Accumulated impairment losses	$ 27,622

Goodwill and Other Intangible63

Goodwill and Other Intangible Assets - Additional Information (Detail)	3 Months Ended	12 Months Ended
	Mar. 31, 2016CountryCommunity	Dec. 31, 2015Unit
Goodwill [Line Items]
Multiplication Value to Cash flows for the determination of fair value of Reporting units | Unit		8
Reporting unit percentage of fair value in excesses of carrying value amount		10.00%
U.S. Operating Segment
Goodwill [Line Items]
Number of reporting unit | Community	19
International Operating Segment
Goodwill [Line Items]
Number of reporting unit | Country	7

Intangible Assets (Detail)

Intangible Assets (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)
Intangible Assets [Line Items]
Intangible assets with finite lives, Beginning balance	$ 99,968
Other, Gross carrying amount	(642)	[1]
Intangible assets with finite lives, Ending balance	99,326
Intangible assets with finite lives, Accumulated amortization, Beginning balance	(59,706)
Accumulated amortization	(1,338)
Other Accumulated Amortization of Intangible Assets	661	[1]
Intangible assets with finite lives, Accumulated amortization, Ending balance	(60,383)
Net intangible assets with finite lives, Beginning balance	40,262
Amortization, intangible assets	(1,338)
Other, Finite lived intangible assets	19	[1]
Net intangible assets with finite lives, Ending balance	38,943
Indefinite-lived Intangible Assets, Trade name, Beginning Balance	299,382
Other, Trade name	166	[1]
Indefinite-lived Intangible Assets, Trade name, Ending Balance	299,548
Total intangible assets - net, Beginning balance	339,644
Accumulated amortization	(1,338)
Other, Total intangible assets - net	185	[1]
Total intangible assets - net, Ending balance	$ 338,491
[1]	Includes non-compete agreement related to the acquisition of U.S. theatres, write-off of a fully amortized vendor contract, and foreign currency translation adjustments.

Estimated Aggregate Future Amor

Estimated Aggregate Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
For the nine months ended December 31, 2016	$ 3,975
For the twelve months ended December 31, 2017	4,957
For the twelve months ended December 31, 2018	4,882
For the twelve months ended December 31, 2019	3,977
For the twelve months ended December 31, 2020	4,252
Thereafter	16,900
Total	$ 38,943	$ 40,262

Impairment of Long-Lived Asse66

Impairment of Long-Lived Assets - Additional Information (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)	Mar. 31, 2015
Indefinite-lived Intangible Assets [Line Items]
Estimated aggregate fair value of long-lived assets impaired during current period	$ 1,770
Remaining operating period assumed for fee owned properties	20 years
Multiple of cash flows used to estimate fair value of long-lived asset	6.5	6.5

Long-Lived Asset Impairment Cha

Long-Lived Asset Impairment Charges (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Impaired Long-Lived Assets Held and Used [Line Items]
Impairment of long-lived assets	$ 492	$ 794
U.S. Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Impairment of long-lived assets	136	794
International Operating Segment
Impaired Long-Lived Assets Held and Used [Line Items]
Impairment of long-lived assets	$ 356	$ 0

Summary of Assets and Liabiliti

Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap liabilities - current	$ (53)	$ (373)
Other investments	87,031	94,973
Other Affiliates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments	87,031	94,973
Other Affiliates | RealD
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments	0	12,900
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap liabilities - current	0	0
Level 1 | Other Affiliates | RealD
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments		12,900
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap liabilities - current	0	0
Level 2 | Other Affiliates | RealD
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments		0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest rate swap liabilities - current	$ (53)	(373)
Level 3 | Other Affiliates | RealD
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Other investments		$ 0

Reconciliation of Beginning and

Reconciliation of Beginning and Ending Balance for Liabilities Measured at Fair Value on Recurring Basis Unobservable Inputs (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balances - Liabilities	$ 373	$ 4,572
Total loss included in accumulated other comprehensive loss	14	236
Settlements	(334)	(1,446)
Ending balance - Liabilities	$ 53	$ 3,362

Foreign Currency Translation -

Foreign Currency Translation - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Foreign Currency Translation [Line Items]
Accumulated other comprehensive loss	$ (260,047)	$ (271,686)
Cumulative foreign currency adjustments	$ (259,633)	$ (273,404)

Summary of Impact of Translatin

Summary of Impact of Translating Financial Statements of Certain of Company's International Subsidiaries (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2016USD ($)	Mar. 31, 2015USD ($)	Dec. 31, 2015
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 13,780	$ (46,675)
Brazil
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 18,298
Exchange Rate	3.6		3.96
Argentina
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ (7,151)
Exchange Rate	14.62		12.95
Colombia
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 1,109
Exchange Rate	3,022.35		3,149.47
Chile
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 1,106
Exchange Rate	691.65		709.16
Peru
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 444
Exchange Rate	3.42		3.46
Other foreign countries
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ (35)
Total International Subsidiaries | Cinemark USA, Inc. Stockholder's Equity
Foreign Currency Translation [Line Items]
Other comprehensive Income (Loss)	$ 13,771

Supplemental Information to Con

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Schedule of Cash Flow, Supplemental [Line Items]
Cash paid for interest		$ 15,503	$ 11,358
Cash paid for income taxes, net of refunds received		6,259	6,552
Noncash investing and financing activities:
Change in accounts payable and accrued expenses for the acquisition of theatre properties and equipment	[1]	3,055	2,384
Theatre properties acquired under capital lease			3,100
Investment in NCM - receipt of common units (see Note 5)		$ 11,111	15,421
Noncash dividends to Cinemark Holdings, Inc.			$ (17,936)
[1]	Additions to theatre properties and equipment included in accounts payable as of March 31, 2016 and December 31, 2015 were $14,209 and $11,154, respectively.

Supplemental Information to C73

Supplemental Information to Condensed Consolidated Statements of Cash Flows (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2016	Dec. 31, 2015
Schedule of Cash Flow, Supplemental [Line Items]
Additions to theatre properties and equipment included in accounts payable	$ 14,209	$ 11,154

Selected Financial Information

Selected Financial Information by Reportable Operating Segment (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Revenues		$ 704,869	$ 645,398
Adjusted EBITDA	[1]	185,153	154,771
Capital expenditures		47,745	85,747
Operating Segments | U.S. Operating Segment
Segment Reporting Information [Line Items]
Revenues		543,915	474,295
Adjusted EBITDA	[1]	144,139	114,757
Capital expenditures		41,198	74,267
Operating Segments | International Operating Segment
Segment Reporting Information [Line Items]
Revenues		164,175	174,333
Adjusted EBITDA	[1]	41,014	40,014
Capital expenditures		6,547	11,480
Eliminations
Segment Reporting Information [Line Items]
Revenues		$ (3,221)	$ (3,230)
[1]	Distributions from equity method investees are reported entirely within the U.S. operating segment.

Reconciliation of Net Income to

Reconciliation of Net Income to Adjusted EBITDA (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Segment Reporting Information [Line Items]
Net income		$ 59,515	$ 43,282
Add (deduct):
Income taxes		33,744	26,611
Interest expense	[1]	28,059	28,207
Other (income) expense	[2]	(10,380)	1,448
Loss on early retirement of debt		13,186
Other cash distributions from equity investees	[3]	8,086	7,264
Depreciation and amortization		49,329	45,332
Impairment of long-lived assets		492	794
Gain on sale of assets and other		(1,779)	(1,450)
Deferred lease expenses		(440)	(703)
Amortization of long-term prepaid rents		471	713
Share based awards compensation expense		4,870	3,273
Adjusted EBITDA	[4]	$ 185,153	$ 154,771
[1]	Includes amortization of debt issue costs.
[2]	Includes interest income, foreign currency exchange (gain) loss and equity in income of affiliates and excludes distributions from NCM.
[3]	Includes cash distributions received from equity investees that were recorded as a reduction of the respective investment balances. In an effort to more closely align our reported Adjusted EBITDA with our operating cash flow and for consistency with our peers, beginning with the three months ended March 31, 2016, Adjusted EBITDA now includes total cash distributions received from equity investees, including the cash distributions recorded as a reduction of the respective investment balance. Adjusted EBITDA for the three months ended March 31, 2015 has been recast to reflect comparable presentations.
[4]	Distributions from equity method investees are reported entirely within the U.S. operating segment.

Selected Financial Informatio76

Selected Financial Information by Geographic Area (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015	Dec. 31, 2015
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ 704,869	$ 645,398
Theatre properties and equipment-net	1,525,859		$ 1,505,069
Reportable Geographical Components | U.S.
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	543,915	474,295
Theatre properties and equipment-net	1,187,753		1,175,535
Reportable Geographical Components | Brazil
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	71,509	78,293
Theatre properties and equipment-net	177,728		163,505
Reportable Geographical Components | Other foreign countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	92,666	96,040
Theatre properties and equipment-net	160,378		$ 166,029
Eliminations
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenues	$ (3,221)	$ (3,230)

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2016USD ($)LeasesTheatreFacility	Mar. 31, 2015USD ($)	Dec. 31, 2015USD ($)
Related Party Transaction [Line Items]
Net receivable from Cinemark Holdings, Inc.	$ 7,642,000		$ 1,171,000
Cash dividends paid to Cinemark Holdings, Inc.	$ 31,150,000	$ 28,750,000
Noncash distributions to Cinemark Holdings, Inc.		17,936,000
Cinemark USA, Inc. Stockholder's Equity
Related Party Transaction [Line Items]
Cash and non-cash dividends paid to Cinemark Holdings, Inc.		46,686,000
Laredo Theatre, Ltd
Related Party Transaction [Line Items]
Company's interest in Laredo	75.00%
Lone Star Theatre's interest in Laredo	25.00%
Ownership interest in Lone Star Theatres held by David Roberts	100.00%
Percentage of common stock held by Chairman of the Board of directors	9.00%
Percentage of management fees based on theatre revenues	5.00%
Maximum amount of theater revenue used to calculate management fees	$ 50,000,000
Percentage of management fees based on theatre revenues in excess	3.00%
Minimum amount of theater revenue used to calculate management fees	$ 50,000,000
Management fee revenues	128,000	135,000
Copper Beech Capital L L C
Related Party Transaction [Line Items]
Amount paid for the use of aircraft	$ 24,000	37,000
Syufy Enterprises, LP
Related Party Transaction [Line Items]
Number of theatres leased | Theatre	15
Number of parking facilities leased | Facility	1
Total number of leases | Leases	16
Number of leases with minimum annual rent | Leases	15
Number of leases without minimum annual rent | Leases	1
Total rent paid to Syufy	$ 6,857,000	$ 5,566,000

Condensed Consolidating Finan78

Condensed Consolidating Financial Statement Information of Subsidiary Guarantors - Additional Information (Detail) $ in Thousands	Mar. 31, 2016USD ($)
5.125% Senior Notes Due 2022
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 400,000
Interest rate	5.125%
4.875% Senior Notes Due 2023
Condensed Consolidating Financial Information [Line Items]
Outstanding aggregate principal amount of Senior Notes	$ 755,000
Interest rate	4.875%

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet Information (Detail) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014
Current assets
Cash and cash equivalents	$ 583,809	$ 588,503	$ 532,727	$ 638,841
Other current assets	102,015	126,612
Accounts receivable from parent or subsidiaries	7,642	1,171
Total current assets	693,466	716,286
Theatre properties and equipment-net	1,525,859	1,505,069
Investment in subsidiaries		0
Other assets	1,916,949	1,906,277
Total assets	4,136,274	4,127,632
Current liabilities
Current portion of long-term debt	8,397	8,405
Current portion of capital lease obligations	18,841	18,780
Accounts payable and accrued expenses	362,068	411,984
Total current liabilities	389,306	439,169
Long-term liabilities
Long-term debt, less current portion	1,793,907	1,772,930
Capital lease obligations, less current portion	206,368	208,952
Other long-term liabilities and deferrals	587,055	593,330
Total long-term liabilities	$ 2,587,330	$ 2,575,212
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ 49,543	$ 49,543
Other stockholder's equity	1,098,680	1,052,603
Total Cinemark USA, Inc. stockholder's equity	1,148,223	1,102,146
Noncontrolling interests	11,415	11,105
Total equity	1,159,638	1,113,251	1,094,068	1,136,723
Total liabilities and equity	4,136,274	4,127,632
Parent Company
Current assets
Cash and cash equivalents	95,068	141,364	67,803	129,505
Other current assets	73,279	78,797
Accounts receivable from parent or subsidiaries	248,023	212,299
Total current assets	416,370	432,460
Theatre properties and equipment-net	553,046	539,082
Investment in subsidiaries	1,399,149	1,326,790
Other assets	1,406,884	1,402,062
Total assets	3,775,449	3,700,394
Current liabilities
Current portion of long-term debt	7,000	7,000
Current portion of capital lease obligations	6,625	6,426
Accounts payable and accrued expenses	208,802	197,268
Total current liabilities	222,427	210,694
Long-term liabilities
Long-term debt, less current portion	1,889,740	1,868,763
Capital lease obligations, less current portion	112,862	114,513
Other long-term liabilities and deferrals	402,197	404,278
Total long-term liabilities	$ 2,404,799	$ 2,387,554
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ 49,543	$ 49,543
Other stockholder's equity	1,098,680	1,052,603
Total Cinemark USA, Inc. stockholder's equity	1,148,223	1,102,146
Noncontrolling interests		0
Total equity	1,148,223	1,102,146
Total liabilities and equity	3,775,449	3,700,394
Subsidiary Guarantors
Current assets
Cash and cash equivalents	112,602	95,865	42,503	77,645
Other current assets	19,031	18,407
Total current assets	131,633	114,272
Theatre properties and equipment-net	613,376	614,821
Investment in subsidiaries	307,978	293,900
Other assets	134,583	135,022
Total assets	1,187,570	1,158,015
Current liabilities
Current portion of capital lease obligations	9,575	9,962
Accounts payable and accrued expenses	87,233	123,759
Accounts payable to parent or subsidiaries	47,201	23,965
Total current liabilities	144,009	157,686
Long-term liabilities
Capital lease obligations, less current portion	65,285	67,440
Other long-term liabilities and deferrals	77,639	77,774
Total long-term liabilities	$ 142,924	$ 145,214
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ 457,368	$ 457,369
Other stockholder's equity	443,269	397,746
Total Cinemark USA, Inc. stockholder's equity	900,637	855,115
Noncontrolling interests		0
Total equity	900,637	855,115
Total liabilities and equity	1,187,570	1,158,015
Subsidiary Non-Guarantors
Current assets
Cash and cash equivalents	376,139	351,274	$ 422,421	431,691
Other current assets	57,970	61,432
Total current assets	434,109	412,706
Theatre properties and equipment-net	359,437	351,166
Investment in subsidiaries		0
Other assets	478,142	475,187
Total assets	1,271,688	1,239,059
Current liabilities
Current portion of long-term debt	1,397	1,405
Current portion of capital lease obligations	2,641	2,392
Accounts payable and accrued expenses	97,152	116,353
Accounts payable to parent or subsidiaries	193,180	187,163
Total current liabilities	294,370	307,313
Long-term liabilities
Long-term debt, less current portion	9,534	9,534
Capital lease obligations, less current portion	28,221	26,999
Other long-term liabilities and deferrals	121,658	118,533
Total long-term liabilities	$ 159,413	$ 155,066
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ 10,239	$ 10,240
Other stockholder's equity	796,251	755,335
Total Cinemark USA, Inc. stockholder's equity	806,490	765,575
Noncontrolling interests	11,415	11,105
Total equity	817,905	776,680
Total liabilities and equity	1,271,688	1,239,059
Eliminations
Current assets
Cash and cash equivalents		0		$ 0
Other current assets	(48,265)	(32,024)
Accounts receivable from parent or subsidiaries	(240,381)	(211,128)
Total current assets	(288,646)	(243,152)
Theatre properties and equipment-net		0
Investment in subsidiaries	(1,707,127)	(1,620,690)
Other assets	(102,660)	(105,994)
Total assets	(2,098,433)	(1,969,836)
Current liabilities
Accounts payable and accrued expenses	(31,119)	(25,396)
Accounts payable to parent or subsidiaries	(240,381)	(211,128)
Total current liabilities	(271,500)	(236,524)
Long-term liabilities
Long-term debt, less current portion	(105,367)	(105,367)
Other long-term liabilities and deferrals	(14,439)	(7,255)
Total long-term liabilities	$ (119,806)	$ (112,622)
Commitments and contingencies
Cinemark USA, Inc.'s stockholder's equity:
Common stock	$ (467,607)	$ (467,609)
Other stockholder's equity	(1,239,520)	(1,153,081)
Total Cinemark USA, Inc. stockholder's equity	(1,707,127)	(1,620,690)
Noncontrolling interests		0
Total equity	(1,707,127)	(1,620,690)
Total liabilities and equity	$ (2,098,433)	$ (1,969,836)

Condensed Consolidating Stateme

Condensed Consolidating Statement of Income Information (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2016	Mar. 31, 2015
Revenues		$ 704,869	$ 645,398
Cost of operations
Theatre operating expenses		504,134	472,359
General and administrative expenses		37,112	37,314
Depreciation and amortization		49,329	45,332
Impairment of long-lived assets		492	794
(Gain) loss on sale of assets and other		(1,779)	(1,450)
Total cost of operations		589,288	554,349
Operating income		115,581	91,049
Other income (expense)
Interest expense	[1]	(28,059)	(28,207)
Loss on early retirement of debt		(13,186)
Distributions from NCM		8,543	8,499
Equity in income of affiliates		7,142	5,239
Other income		3,238	(6,687)
Total other income (expense)		(22,322)	(21,156)
Income before income taxes		93,259	69,893
Income taxes		33,744	26,611
Net income		59,515	43,282
Less: Net income attributable to noncontrolling interests		521	381
Net income attributable to Cinemark USA, Inc.		58,994	42,901
Parent Company
Revenues		245,850	216,573
Cost of operations
Theatre operating expenses		192,175	176,282
General and administrative expenses		3,462	4,189
Depreciation and amortization		16,494	14,121
Impairment of long-lived assets		136	61
(Gain) loss on sale of assets and other		(1,753)	1,415
Total cost of operations		210,514	196,068
Operating income		35,336	20,505
Other income (expense)
Interest expense		(25,168)	(25,249)
Loss on early retirement of debt		(13,186)
Distributions from NCM		1,310	1,724
Equity in income of affiliates		59,592	45,085
Other income		78	46
Total other income (expense)		22,626	21,606
Income before income taxes		57,962	42,111
Income taxes		(1,032)	(790)
Net income		58,994	42,901
Less: Net income attributable to noncontrolling interests			0
Net income attributable to Cinemark USA, Inc.		58,994	42,901
Subsidiary Guarantors
Revenues		297,397	258,963
Cost of operations
Theatre operating expenses		200,647	178,234
General and administrative expenses		23,949	18,991
Depreciation and amortization		19,639	17,507
Impairment of long-lived assets			733
(Gain) loss on sale of assets and other		(112)	(1,582)
Total cost of operations		244,123	213,883
Operating income		53,274	45,080
Other income (expense)
Interest expense		(1,975)	(2,199)
Equity in income of affiliates		16,706	11,615
Other income		3	11
Total other income (expense)		14,734	9,427
Income before income taxes		68,008	54,507
Income taxes		19,863	16,798
Net income		48,145	37,709
Less: Net income attributable to noncontrolling interests			0
Net income attributable to Cinemark USA, Inc.		48,145	37,709
Subsidiary Non-Guarantors
Revenues		173,285	180,207
Cost of operations
Theatre operating expenses		122,975	128,188
General and administrative expenses		9,701	14,134
Depreciation and amortization		13,196	13,704
Impairment of long-lived assets		356	0
(Gain) loss on sale of assets and other		86	(1,283)
Total cost of operations		146,314	154,743
Operating income		26,971	25,464
Other income (expense)
Interest expense		(1,217)	(775)
Distributions from NCM		7,233	6,775
Equity in income of affiliates		6,897	5,200
Other income		3,458	(6,728)
Total other income (expense)		16,371	4,472
Income before income taxes		43,342	29,936
Income taxes		14,913	10,603
Net income		28,429	19,333
Less: Net income attributable to noncontrolling interests		521	381
Net income attributable to Cinemark USA, Inc.		27,908	18,952
Eliminations
Revenues		(11,663)	(10,345)
Cost of operations
Theatre operating expenses		(11,663)	(10,345)
General and administrative expenses			0
Depreciation and amortization			0
Impairment of long-lived assets			0
(Gain) loss on sale of assets and other			0
Total cost of operations		(11,663)	(10,345)
Operating income			0
Other income (expense)
Interest expense		301	16
Distributions from NCM			0
Equity in income of affiliates		(76,053)	(56,661)
Other income		(301)	(16)
Total other income (expense)		(76,053)	(56,661)
Income before income taxes		(76,053)	(56,661)
Income taxes			0
Net income		(76,053)	(56,661)
Less: Net income attributable to noncontrolling interests			0
Net income attributable to Cinemark USA, Inc.		$ (76,053)	$ (56,661)
[1]	Includes amortization of debt issue costs.

Condensed Consolidating State81

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net income	$ 59,515	$ 43,282
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	201	757
Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes		766
Other comprehensive income of equity method investments	(322)	384
Foreign currency translation adjustments	13,780	(46,675)
Total other comprehensive income (loss), net of tax	13,659	(44,768)
Total comprehensive income (loss), net of tax	73,174	(1,486)
Comprehensive income attributable to noncontrolling interests	(530)	(387)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	72,644	(1,873)
Parent Company
Net income	58,994	42,901
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes	201	757
Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes		766
Other comprehensive income of equity method investments	(322)	384
Foreign currency translation adjustments	13,771	(46,681)
Total other comprehensive income (loss), net of tax	13,650	(44,774)
Total comprehensive income (loss), net of tax	72,644	(1,873)
Comprehensive income attributable to noncontrolling interests		0
Comprehensive income (loss) attributable to Cinemark USA, Inc.	72,644	(1,873)
Subsidiary Guarantors
Net income	48,145	37,709
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes		0
Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes		0
Other comprehensive income of equity method investments		0
Foreign currency translation adjustments		0
Total other comprehensive income (loss), net of tax		0
Total comprehensive income (loss), net of tax	48,145	37,709
Comprehensive income attributable to noncontrolling interests		0
Comprehensive income (loss) attributable to Cinemark USA, Inc.	48,145	37,709
Subsidiary Non-Guarantors
Net income	28,429	19,333
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes		0
Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes		0
Other comprehensive income of equity method investments	(322)	367
Foreign currency translation adjustments	13,780	(46,675)
Total other comprehensive income (loss), net of tax	13,458	(46,308)
Total comprehensive income (loss), net of tax	41,887	(26,975)
Comprehensive income attributable to noncontrolling interests	(530)	(387)
Comprehensive income (loss) attributable to Cinemark USA, Inc.	41,357	(27,362)
Eliminations
Net income	(76,053)	(56,661)
Other comprehensive income (loss), net of tax
Unrealized gain due to fair value adjustments on interest rate swap agreements, net of settlements, net of taxes		0
Unrealized gain due to fair value adjustments on available-for-sale securities, net of taxes		0
Other comprehensive income of equity method investments	322	(367)
Foreign currency translation adjustments	(13,771)	46,681
Total other comprehensive income (loss), net of tax	(13,449)	46,314
Total comprehensive income (loss), net of tax	(89,502)	(10,347)
Comprehensive income attributable to noncontrolling interests		0
Comprehensive income (loss) attributable to Cinemark USA, Inc.	$ (89,502)	$ (10,347)

Condensed Consolidating State82

Condensed Consolidating Statement of Comprehensive Income (Loss) Information (Parenthetical) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Unrealized gain (loss) due to fair value adjustments on interest rate swap agreements, tax	$ 118	$ 453
Unrealized gain due to fair value adjustments on available-for-sale securities, taxes		444
Foreign currency translation adjustments, taxes	$ 979	$ 0

Condensed Consolidating State83

Condensed Consolidating Statement of Cash Flows Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Operating activities
Net income	$ 59,515	$ 43,282
Adjustments to reconcile net income to cash provided by (used for) operating activities	49,366	33,692
Changes in assets and liabilities	(41,432)	(52,123)
Net cash provided by (used for) operating activities	67,449	24,851
Investing activities
Additions to theatre properties and equipment	(47,745)	(85,747)
Proceeds from sale of theatre properties and equipment and other	347	2,388
Proceeds from sale of marketable securities	13,451
Investment in joint ventures and other	(12)	(713)
Net cash provided by (used for) investing activities	(49,259)	(86,723)
Financing activities
Dividends paid to parent	(31,150)	(28,750)
Proceeds from issuance of Senior Notes, net of discount	222,750
Retirement of Senior Subordinated Notes	(200,000)
Repayments of long-term debt	(1,758)	(1,758)
Payments of debt issue costs	(3,675)
Payments on capital leases	(4,572)	(3,913)
Other	(4,107)	(2,504)
Net cash provided by (used for) financing activities	(22,512)	(36,925)
Effect of exchange rate changes on cash and cash equivalents	(372)	(7,317)
Decrease in cash and cash equivalents	(4,694)	(106,114)
Cash and cash equivalents:
Beginning of period	588,503	638,841
End of period	583,809	532,727
Brazil
Investing activities
Acquisition of theatre		(2,651)
U.S.
Investing activities
Acquisition of theatre	(15,300)
Parent Company
Operating activities
Net income	58,994	42,901
Adjustments to reconcile net income to cash provided by (used for) operating activities	(51,423)	(46,642)
Changes in assets and liabilities	(15,778)	(6,524)
Net cash provided by (used for) operating activities	(8,207)	(10,265)
Investing activities
Additions to theatre properties and equipment	(23,120)	(21,887)
Proceeds from sale of theatre properties and equipment and other		2
Proceeds from sale of marketable securities	13,451
Dividends received from subsidiaries	433
Investment in joint ventures and other		0
Net cash provided by (used for) investing activities	(24,536)	(21,885)
Financing activities
Dividends paid to parent	(31,150)	(28,750)
Proceeds from issuance of Senior Notes, net of discount	222,750
Retirement of Senior Subordinated Notes	(200,000)
Repayments of long-term debt	(1,750)	(1,750)
Payments of debt issue costs	(3,675)
Payments on capital leases	(1,451)	(1,296)
Other	1,723	2,244
Net cash provided by (used for) financing activities	(13,553)	(29,552)
Effect of exchange rate changes on cash and cash equivalents		0
Decrease in cash and cash equivalents	(46,296)	(61,702)
Cash and cash equivalents:
Beginning of period	141,364	129,505
End of period	95,068	67,803
Parent Company | Brazil
Investing activities
Acquisition of theatre		0
Parent Company | U.S.
Investing activities
Acquisition of theatre	(15,300)
Subsidiary Guarantors
Operating activities
Net income	48,145	37,709
Adjustments to reconcile net income to cash provided by (used for) operating activities	7,200	14,710
Changes in assets and liabilities	(12,740)	(30,303)
Net cash provided by (used for) operating activities	42,605	22,116
Investing activities
Additions to theatre properties and equipment	(18,022)	(51,329)
Proceeds from sale of theatre properties and equipment and other	301	987
Dividends received from subsidiaries	5
Investment in joint ventures and other		0
Net cash provided by (used for) investing activities	(17,716)	(50,342)
Financing activities
Dividends paid to parent		0
Repayments of long-term debt		0
Payments on capital leases	(2,542)	(2,168)
Other	(5,610)	(4,748)
Net cash provided by (used for) financing activities	(8,152)	(6,916)
Effect of exchange rate changes on cash and cash equivalents		0
Decrease in cash and cash equivalents	16,737	(35,142)
Cash and cash equivalents:
Beginning of period	95,865	77,645
End of period	112,602	42,503
Subsidiary Guarantors | Brazil
Investing activities
Acquisition of theatre		0
Subsidiary Non-Guarantors
Operating activities
Net income	28,429	19,333
Adjustments to reconcile net income to cash provided by (used for) operating activities	17,536	8,963
Changes in assets and liabilities	(12,914)	(15,296)
Net cash provided by (used for) operating activities	33,051	13,000
Investing activities
Additions to theatre properties and equipment	(6,603)	(12,531)
Proceeds from sale of theatre properties and equipment and other	46	1,399
Investment in joint ventures and other	(12)	(713)
Net cash provided by (used for) investing activities	(6,569)	(14,496)
Financing activities
Dividends paid to parent	(438)
Repayments of long-term debt	(8)	(8)
Payments on capital leases	(579)	(449)
Other	(220)
Net cash provided by (used for) financing activities	(1,245)	(457)
Effect of exchange rate changes on cash and cash equivalents	(372)	(7,317)
Decrease in cash and cash equivalents	24,865	(9,270)
Cash and cash equivalents:
Beginning of period	351,274	431,691
End of period	376,139	422,421
Subsidiary Non-Guarantors | Brazil
Investing activities
Acquisition of theatre		(2,651)
Eliminations
Operating activities
Net income	(76,053)	(56,661)
Adjustments to reconcile net income to cash provided by (used for) operating activities	76,053	56,661
Changes in assets and liabilities		0
Net cash provided by (used for) operating activities		0
Investing activities
Additions to theatre properties and equipment		0
Proceeds from sale of theatre properties and equipment and other		0
Dividends received from subsidiaries	(438)
Investment in joint ventures and other		0
Net cash provided by (used for) investing activities	(438)	0
Financing activities
Dividends paid to parent	438	0
Repayments of long-term debt		0
Payments on capital leases		0
Other		0
Net cash provided by (used for) financing activities	438	0
Effect of exchange rate changes on cash and cash equivalents		0
Decrease in cash and cash equivalents		0
Cash and cash equivalents:
Beginning of period	$ 0	0
Eliminations | Brazil
Investing activities
Acquisition of theatre		$ 0